FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Michael Kattan

Research Profile

Disorders

Concepts & Ideas

Chemicals & Drugs

Procedures

Anatomy

Prostate

Physiology

Disease Progression

Co-author Network

Publications

TOP 3
Michael W Kattan; Oliver Sartor; Andrew J Stephenson; Changhong Yu; Bertrand Tombal
Clinicians Versus Nomogram: Predicting Future Technetium-99m Bone Scan Positivity in Patients With Rising Prostate-specific Antigen After Radical Prostatectomy for Prostate Cancer.
Johan L Dikken; Mithat Gonen; Michael W Kattan; Manish A Shah; Cornelis J H van de Velde; Marcel Verheij; Raymond E Baser; Murray F Brennan; Daniel G Coit
Conditional probability of survival nomogram for 1-, 2-, and 3-year survivors after an R0 resection for gastric cancer.
J Eric Jelovsek; Annalisa Piccorelli; Elena Tunitsky-Bitton; Matthew D Barber; Michael W Kattan
Prediction models for postpartum urinary and fecal incontinence in primiparous women.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Michael Kattan (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Michael W Kattan; Oliver Sartor; Andrew J Stephenson; Changhong Yu; Bertrand Tombal
Clinicians Versus Nomogram: Predicting Future Technetium-99m Bone Scan Positivity in Patients With Rising Prostate-specific Antigen After Radical Prostatectomy for Prostate Cancer.
Urology 2013;81(5):956-61.
2013: Johan L Dikken; Mithat Gonen; Michael W Kattan; Manish A Shah; Cornelis J H van de Velde; Marcel Verheij; Raymond E Baser; Murray F Brennan; Daniel G Coit
Conditional probability of survival nomogram for 1-, 2-, and 3-year survivors after an R0 resection for gastric cancer.
Annals of surgical oncology 2013;20(5):1623-30.
2013: J Eric Jelovsek; Annalisa Piccorelli; Elena Tunitsky-Bitton; Matthew D Barber; Michael W Kattan
Prediction models for postpartum urinary and fecal incontinence in primiparous women.
Female pelvic medicine & reconstructive surgery 2013;19(2):110-8.
2013: Chris H Bangma; Lara Bellardita; Meelan Bul; Peter R Carroll; Louis J Denis; Mark Emberton; Caroline M Hoeks; Guido Jenster; Yoshiyuki Kakehi; Michael W Kattan; Laurence H Klotz; Ida J Korfage; Janet A Lane; Chris Parker; Tom Pickles; Antti Rannikko; Monique J Roobol; Fritz H Schröder; Axel Semjonow; Ewout W Steyerberg; Bruce J Trock; Theo H van der Kwast; Riccardo Valdagni
Active surveillance for low-risk prostate cancer.
Critical reviews in oncology/hematology 2013;85(3):295-302.
2013: Dharam J Kumbhani; A Michael Lincoff; Brian J Wells; Changhong Yu; Susana Arrigain; Eugene Blackstone; Stephen G Ellis; Marlene Goormastic; Anil Jain; Michael W Kattan
Predictive models for short- and long-term adverse outcomes following discharge in a contemporary population with acute coronary syndromes.
American journal of cardiovascular disease 2013;3(1):39-52.
2012: Richard Savdie; Daniel Spernat; Robert L Sutherland; James Symons; Changhong Yu; Carlo Yuen; Phillip Brenner; Gerald Fogarty; Anne-Maree Haynes; Raj S Jagavkar; Michael W Kattan; Jayne Matthews; Ruth A Pe Benito; Krishan K Rasiah; Phillip D Stricker
High-dose rate brachytherapy compared with open radical prostatectomy for the treatment of high-risk prostate cancer: 10 year biochemical freedom from relapse.
BJU international 2012;110 Suppl 4():71-6.
2012: Michael W Kattan; Thomas A Gerds
Stages of prediction model comparison.
European urology 2012;62(4):597-9; discussion 599-600.
2012: José Luiz B Bevilacqua; Yu Changhong; Michael W Kattan; Rosalina J Koifman; Sergio Koifman; Inês E Mattos; Anke Bergmann
Nomograms for predicting the risk of arm lymphedema after axillary dissection in breast cancer.
Annals of surgical oncology 2012;19(8):2580-9.
2012: Nicholas F Marko; Tianming Gao; Michael W Kattan; Zhiyuan Xu; Robert J Weil
Predicting survival in women with breast cancer and brain metastasis: a nomogram outperforms current survival prediction models.
Cancer 2012;118(15):3749-57.
2012: Brandon K Isariyawongse; Michael W Kattan
Prediction tools in surgical oncology.
Surgical oncology clinics of North America 2012;21(3):439-47, viii-ix.
2012: Jill S Barnholtz-Sloan; James J Dignam; Mitchell Machtay; Minesh Mehta; Andrew E Sloan; Paul W Sperduto; Jaime Vengoechea; Michael A Vogelbaum; Meihua Wang; Changhong Yu; Michael W Kattan
A nomogram for individualized estimation of survival among patients with brain metastasis.
Neuro-oncology 2012;14(7):910-8.
2012: Dympna M Kelly; Judy McCoy; Changhong Yu; Wael Barsoum; Renee Bennett; Derek Boerner; Nancy Brown; Bijan Eghtesad; John J Fung; Michael W Kattan
Predicting the discharge status after liver transplantation at a single center: a new approach for a new era.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2012;18(7):796-802.
2012: Ickwon Choi; Michael W Kattan; Brian J Wells; Changhong Yu
A hybrid approach to survival model building using integration of clinical and molecular information in censored data.
IEEE/ACM transactions on computational biology and bioinformatics / IEEE, ACM 2012;9(4):1091-1105.
2012: Michael W Kattan; Louis Potters
Validation and comparison of the two Kattan nomograms in patients with prostate cancer treated with (125) iodine brachytherapy.
BJU international 2012;109(11):1665.
2012: Tyler M Muffly; Abigail Shniter; Matthew D Barber; Matthew T Karafa; Michael W Kattan; J Eric Jelovsek
Nomogram to predict successful placement in surgical subspecialty fellowships using applicant characteristics.
Journal of surgical education 2012;69(3):364-70.
2012: Brandon K Isariyawongse; Michael W Kattan
Editorial comment.
The Journal of urology 2012;187(5):1560.
2012: Adam S Kibel; Eric A Klein; Jessica D Lubahn; Jeff M Michalski; Jay F Piccirillo; Danny M Rabah; Chandana A Reddy; Jay P Ciezki; Joseph O Deasy; Jennifer Haslag-Minoff; Dorina Kallogjeri; Michael W Kattan; Changhong Yu; Andrew J Stephenson
Survival among men with clinically localized prostate cancer treated with radical prostatectomy or radiation therapy in the prostate specific antigen era.
The Journal of urology 2012;187(4):1259-65.
2012: A Ari Hakimi; Gloria Y F Ho; Michael W Kattan; Ilir Agalliu; Reza Ghavamian; Chaghong Yu; Farhang Rabbani
Detection of prostate cancer in an ethnically diverse, disadvantaged population with multiple prostate specific antigen measurements before biopsy.
The Journal of urology 2012;187(4):1234-40.
2012: Monique J Roobol; Gilles Salama; Fritz H Schröder; Andrew J Vickers; Arnauld Villers; Donna Ankerst; George Bartsch; Amine Benchikh; Jenny Donovan; Stephen J Freedland; Freddie Hamdy; Wolfgang Horninger; Jonas Hugosson; J Stephen Jones; Michael W Kattan; Eric A Klein; Helmut Klocker; Hans Lilja; Daniel M Moreira; David Neal; Dipen J Parekh; Ewout W Steyerberg
Importance of prostate volume in the European Randomised Study of Screening for Prostate Cancer (ERSPC) risk calculators: results from the prostate biopsy collaborative group.
World journal of urology 2012;30(2):149-55.
2012: Joyce N Barlin; Nadeem R Abu-Rustum; Richard R Barakat; Emily K Hill; Jae Huh; Michael W Kattan; Valentin Kolev; Douglas A Levine; Yukio Sonoda; Changhong Yu; Oliver Zivanovic; Dennis S Chi
Nomogram for predicting 5-year disease-specific mortality after primary surgery for epithelial ovarian cancer.
Gynecologic oncology 2012;125(1):25-30.
2012: Riccardo Valdagni; Vittorio Vavassori; Changhong Yu; Micaela Baccolini; Carla Bianchi; Emanuela Cagna; Gianni Fellin; Pietro Gabriele; Maria Olga Giganti; Michael W Kattan; Flora Anna Mauro; Loris Menegotti; Angelo F Monti; Tiziana Rancati; Michele Stasi; Claudio Fiorino
Is it time to tailor the prediction of radio-induced toxicity in prostate cancer patients? Building the first set of nomograms for late rectal syndrome.
International journal of radiation oncology, biology, physics 2012;82(5):1957-66.
2012: Ewout W Steyerberg; Michael W Kattan; Hester Floor Lingsma; Michael J Pencina; Andrew J Vickers; Ben Van Calster
Assessing the incremental value of diagnostic and prognostic markers: a review and illustration.
European journal of clinical investigation 2012;42(2):216-28.
2012: Andrei Brateanu; Michael W Kattan; Jeff Olender; Changhong Yu; Craig Nielsen
A nomogram to predict the probability of passing the American Board of Internal Medicine examination.
Medical education online 2012;17():18810.
2011: Michael W Kattan; Thomas A Gerds
Making and evaluating a statistical prediction model for the absolute risk of prostate cancer recurrence.
Cancer 2011;117(22):5026-8.
2011: Safina Ali; Ian Ganly; Michael W Kattan; Frank L Palmer; Jatin P Shah; Ashok Shaha; Changhong Yu; Snehal G Patel
Nomogram to aid selection of patients for short-stay thyroidectomy based on risk of postoperative hypocalcemia.
Archives of otolaryngology--head & neck surgery 2011;137(11):1154-60.
2011: Osama M Zaytoun; Michael W Kattan; Jianbo Li; Ayman S Moussa; Changhong Yu; J Stephen Jones
Development of improved nomogram for prediction of outcome of initial prostate biopsy using readily available clinical information.
Urology 2011;78(2):392-8.
2011: Robert K Nam; David Bell; Joseph L Chin; Eleftherios P Diamandis; Jonathan Izawa; Michael W Kattan; Laurence H Klotz; D Andrew Loblaw; Ricardo Rendon; Christopher Sherman; Rajiv Singal; Aleksandra Stanimirovic; Linda Sugar; John Trachtenberg; Vasundara Venkateswaran; Changhong Yu; Steven A Narod
Prospective multi-institutional study evaluating the performance of prostate cancer risk calculators.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(22):2959-64.
2011: Carvell T Nguyen; Michael W Kattan
How to tell if a new marker improves prediction.
European urology 2011;60(2):226-8; discussion 228-30.
2011: Ickwon Choi; Brian J Wells; Changhong Yu; Michael W Kattan
An empirical approach to model selection through validation for censored survival data.
Journal of biomedical informatics 2011;44(4):595-606.
2011: Andrew J Vickers; Caroline J Savage; Fernando J Bianco; Eric A Klein; Michael W Kattan; Fernando P Secin; Bertrand D Guilloneau; Peter T Scardino
Surgery confounds biology: the predictive value of stage-, grade- and prostate-specific antigen for recurrence after radical prostatectomy as a function of surgeon experience.
International journal of cancer. Journal international du cancer 2011;128(7):1697-702.
2011: Michael W Kattan; Changhong Yu; Laurent Salomon; Kinjal Vora; Karim Touijer; Bertrand Guillonneau
Development and validation of preoperative nomogram for disease recurrence within 5 years after laparoscopic radical prostatectomy for prostate cancer.
Urology 2011;77(2):396-401.
2011: Ramzi Rajab; Gabrielle Fisher; Michael W Kattan; Christopher S Foster; Henrik Møller; Tim Oliver; Victor Reuter; Peter T Scardino; Jack Cuzick; Daniel M Berney
An improved prognostic model for stage T1a and T1b prostate cancer by assessments of cancer extent.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2011;24(1):58-63.
2010: Michael C Lee; Ayman S Moussa; Changhong Yu; Michael W Kattan; Cristina Magi-Galluzzi; J Stephen Jones
Multifocal high grade prostatic intraepithelial neoplasia is a risk factor for subsequent prostate cancer.
The Journal of urology 2010;184(5):1958-62.
2010: Ramzi Rajab; Gabrielle Fisher; Michael W Kattan; Christopher S Foster; Tim Oliver; Henrik Møller; Victor E Reuter; Peter T Scardino; Jack Cuzick; Daniel M Berney
Measurements of cancer extent in a conservatively treated prostate cancer biopsy cohort.
Virchows Archiv : an international journal of pathology 2010;457(5):547-53.
2010: Ayman S Moussa; J Stephen Jones; Changhong Yu; Khaled Fareed; Michael W Kattan
Development and validation of a nomogram for predicting a positive repeat prostate biopsy in patients with a previous negative biopsy session in the era of extended prostate sampling.
BJU international 2010;106(9):1309-14.
2010: Jesse D Schold; Titte R Srinivas; Emilio D Poggio; Brian R Stephany; Stuart M Flechner; David A Goldfarb; Michael W Kattan
Hidden selection bias deriving from donor organ characteristics does not affect performance evaluations of kidney transplant centers.
Medical care 2010;48(10):907-14.
2010: Andrew J Vickers; Angel M Cronin; Monique J Roobol; Jonas Hugosson; J Stephen Jones; Michael W Kattan; Eric Klein; Freddie Hamdy; David Neal; Jenny Donovan; Dipen J Parekh; Donna Ankerst; George Bartsch; Helmut Klocker; Wolfgang Horninger; Amine Benchikh; Gilles Salama; Arnauld Villers; Steve J Freedland; Daniel M Moreira; Fritz H Schröder; Hans Lilja
The relationship between prostate-specific antigen and prostate cancer risk: the Prostate Biopsy Collaborative Group.
Clinical cancer research : an official journal of the American Association for Cancer Research 2010;16(17):4374-81.
2010: Wael K Barsoum; Trevor G Murray; Alison K Klika; Karen Green; Sara Lyn Miniaci; Brian J Wells; Michael W Kattan
Predicting patient discharge disposition after total joint arthroplasty in the United States.
The Journal of arthroplasty 2010;25(6):885-92.
2010: Timothy R Donahue; Michael W Kattan; Scott D Nelson; William D Tap; Frederick R Eilber; Fritz C Eilber
Evaluation of neoadjuvant therapy and histopathologic response in primary, high-grade retroperitoneal sarcomas using the sarcoma nomogram.
Cancer 2010;116(16):3883-91.
2010: Jarrod E Dalton; Michael W Kattan
Recent advances in evaluating the prognostic value of a marker.
Scandinavian journal of clinical and laboratory investigation. Supplementum 2010;242():59-62.
2010: Michael W Kattan
Editorial comment.
Urology 2010;75(6):1371; author reply 1371-2.
2010: Daniel A Shoskes; J Curtis Nickel; Michael W Kattan
Phenotypically directed multimodal therapy for chronic prostatitis/chronic pelvic pain syndrome: a prospective study using UPOINT.
Urology 2010;75(6):1249-53.
2010: Louis Potters; Mack Roach; Brian J Davis; Richard G Stock; Jay P Ciezki; Michael J Zelefsky; Nelson N Stone; Paul A Fearn; Changhong Yu; Katsuto Shinohara; Michael W Kattan
Postoperative nomogram predicting the 9-year probability of prostate cancer recurrence after permanent prostate brachytherapy using radiation dose as a prognostic variable.
International journal of radiation oncology, biology, physics 2010;76(4):1061-5.
2010: Alex Z Fu; Scott B Cantor; Michael W Kattan
Use of nomograms for personalized decision-analytic recommendations.
Medical decision making : an international journal of the Society for Medical Decision Making 2010;30(2):267-74.
2010: Robert Patrick; Laura Buccini; Michael W Kattan
Tailored cancer outcome prediction and informed consent.
Seminars in oncology 2010;37(1):47-52.
2010: Michael W Kattan; Joe Marasco
What is a real nomogram?
Seminars in oncology 2010;37(1):23-6.
2010: Carvell T Nguyen; Changhong Yu; Ayman Moussa; Michael W Kattan; J Stephen Jones
Performance of prostate cancer prevention trial risk calculator in a contemporary cohort screened for prostate cancer and diagnosed by extended prostate biopsy.
The Journal of urology 2010;183(2):529-33.
2010: Ayman S Moussa; Michael W Kattan; Ryan K Berglund; Changhong Yu; Khaled Fareed; J Stephen Jones
A nomogram for predicting upgrading in patients with low- and intermediate-grade prostate cancer in the era of extended prostate sampling.
BJU international 2010;105(3):352-8.
2010: Carvell T Nguyen; Andrew J Stephenson; Michael W Kattan
Are nomograms needed in the management of bladder cancer?
Urologic oncology 2010;28(1):102-7.
2010: Michael W Kattan
Evaluating a marker's contribution to a nomogram: the GEMCaP example.
Clinical cancer research : an official journal of the American Association for Cancer Research 2010;16(1):1-3.
2010: Ewout W Steyerberg; Andrew J Vickers; Nancy R Cook; Thomas Gerds; Mithat Gonen; Nancy Obuchowski; Michael J Pencina; Michael W Kattan
Assessing the performance of prediction models: a framework for traditional and novel measures.
Epidemiology (Cambridge, Mass.) 2010;21(1):128-38.
2010: Carvell T Nguyen; Alex Z Fu; Timothy D Gilligan; Brian J Wells; Eric A Klein; Michael W Kattan; Andrew J Stephenson
Defining the optimal treatment for clinical stage I nonseminomatous germ cell testicular cancer using decision analysis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(1):119-25.
2009: Shahrokh F Shariat; Michael W Kattan; Andrew J Vickers; Pierre I Karakiewicz; Peter T Scardino
Critical review of prostate cancer predictive tools.
Future oncology (London, England) 2009;5(10):1555-84.
2009: Andrew J Vickers; Angel M Cronin; Michael W Kattan; Mithat Gonen; Peter T Scardino; Matthew I Milowsky; Guido Dalbagni; Bernard H Bochner
Clinical benefits of a multivariate prediction model for bladder cancer: a decision analytic approach.
Cancer 2009;115(23):5460-9.
2009: Andrew J Stephenson; David P Wood Jr; Michael W Kattan; Eric A Klein; Peter T Scardino; James A Eastham; Brett S Carver
Location, extent and number of positive surgical margins do not improve accuracy of predicting prostate cancer recurrence after radical prostatectomy.
The Journal of urology 2009;182(4):1357-63.
2009: Andrew J Stephenson; Michael W Kattan; James A Eastham; Fernando J Bianco; Ofer Yossepowitch; Andrew J Vickers; Eric A Klein; David P Wood Jr; Peter T Scardino
Prostate cancer-specific mortality after radical prostatectomy for patients treated in the prostate-specific antigen era.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(26):4300-5.
2009: Michael W Kattan
Editorial comment.
Urology 2009;74(3):664.
2009: Michael W Kattan
Prediction models for transitional cell carcinoma.
The Journal of urology 2009;182(2):423-4.
2009: Michael Fuchsjäger; Amita Dave; Hedvig Hricak; Liang Wang; Karim Touijer; John F Donohue; James A Eastham; Michael W Kattan
Magnetic resonance imaging in the prediction of biochemical recurrence of prostate cancer after radical prostatectomy.
BJU international 2009;104(3):315-20.
2009: Carvell T Nguyen; Michael W Kattan
Development of a prostate cancer metagram: a solution to the dilemma of which prediction tool to use in patient counseling.
Cancer 2009;115(13 Suppl):3039-45.
2009: Carvell T Nguyen; Michael J Zelefsky; Michael W Kattan
The current state of brachytherapy nomograms for patients with clinically localized prostate cancer.
Cancer 2009;115(13 Suppl):3121-7.
2009: Sak Kudahetti; Gabrielle Fisher; Laurence Ambroisine; Christopher Foster; Victor E Reuter; James A Eastham; Henrik Møller; Michael W Kattan; Colin S Cooper; Peter T Scardino; Jack Cuzick; Daniel M Berney
p53 immunochemistry is an independent prognostic marker for outcome in conservatively treated prostate cancer.
BJU international 2009;104(1):20-4.
2009: Kevin M Pantalone; Michael W Kattan; Changhong Yu; Brian J Wells; Susana Arrigain; Anil Jain; Ashish Atreja; Robert S Zimmerman
The risk of developing coronary artery disease or congestive heart failure, and overall mortality, in type 2 diabetic patients receiving rosiglitazone, pioglitazone, metformin, or sulfonylureas: a retrospective analysis.
Acta diabetologica 2009;46(2):145-54.
2009: Vincenzo Ficarra; Giacomo Novara; Rafael Boscolo Berto; Walter Artibani; Michael W Kattan
How accurate are present risk group assignment tools in penile cancer?
World journal of urology 2009;27(2):155-60.
2009: D M Berney; A Gopalan; S Kudahetti; G Fisher; L Ambroisine; C S Foster; Victor E Reuter; James A Eastham; Henrik Møller; Michael W Kattan; W Gerald; C Cooper; Peter T Scardino; Jack Cuzick
Ki-67 and outcome in clinically localised prostate cancer: analysis of conservatively treated prostate cancer patients from the Trans-Atlantic Prostate Group study.
British journal of cancer 2009;100(6):888-93.
2009: H Y Tiong; David A Goldfarb; Michael W Kattan; Joan M Alster; Lucy W Thuita; C Yu; A Wee; Emilio D Poggio
Nomograms for predicting graft function and survival in living donor kidney transplantation based on the UNOS Registry.
The Journal of urology 2009;181(3):1248-55.
2009: Michael W Kattan; Andrew J Vickers; Changhong Yu; Fernando J Bianco; Angel M Cronin; James A Eastham; Eric A Klein; Alwyn M Reuther; Jose Edson Pontes; Peter T Scardino
Preoperative and postoperative nomograms incorporating surgeon experience for clinically localized prostate cancer.
Cancer 2009;115(5):1005-10.
2009: Riccardo Valdagni; Peter T Scardino; Louis Denis; Michael W Kattan
Predictive modeling in prostate cancer: a conference summary.
European urology 2009;55(2):300-2.
2009: Nelson N Stone; Louis Potters; Brian J Davis; Jay P Ciezki; Michael J Zelefsky; Mack Roach; Katsuto Shinohara; Paul Fearn; Michael W Kattan; Richard G Stock
Multicenter analysis of effect of high biologic effective dose on biochemical failure and survival outcomes in patients with Gleason score 7-10 prostate cancer treated with permanent prostate brachytherapy.
International journal of radiation oncology, biology, physics 2009;73(2):341-6.
2008: Shahrokh F Shariat; Pierre I Karakiewicz; Claus G Roehrborn; Michael W Kattan
An updated catalog of prostate cancer predictive tools.
Cancer 2008;113(11):3075-99.
2008: Brian J Wells; Anil Jain; Susana Arrigain; Changhong Yu; Wayne A Rosenkrans; Michael W Kattan
Predicting 6-year mortality risk in patients with type 2 diabetes.
Diabetes care 2008;31(12):2301-6.
2008: Brian R Lane; Michael W Kattan
Prognostic models and algorithms in renal cell carcinoma.
The Urologic clinics of North America 2008;35(4):613-25; vii.
2008: Neil D Gross; Snehal G Patel; Andre L Carvalho; Pen-Yuan Chu; Luis P Kowalski; Jay O Boyle; Jatin P Shah; Michael W Kattan
Nomogram for deciding adjuvant treatment after surgery for oral cavity squamous cell carcinoma.
Head & neck 2008;30(10):1352-60.
2008: Robert J Motzer; Ronald M Bukowski; Robert A Figlin; Thomas E Hutson; M Dror Michaelson; Sindy T Kim; Charles M Baum; Michael W Kattan
Prognostic nomogram for sunitinib in patients with metastatic renal cell carcinoma.
Cancer 2008;113(7):1552-8.
2008: Alex Z Fu; Michael W Kattan
Utilities should not be multiplied: evidence from the preference-based scores in the United States.
Medical care 2008;46(9):984-90.
2008: Michael W Kattan
Editorial comment on: development, validation, and head-to-head comparison of logistic regression-based nomograms and artificial neural network models predicting prostate cancer on initial extended biopsy.
European urology 2008;54(3):611.
2008: Andrew J Vickers; Ethan Basch; Michael W Kattan
Against diagnosis.
Annals of internal medicine 2008;149(3):200-3.
2008: Michael W Kattan
Should I use this nomogram?
BJU international 2008;102(4):421-2.
2008: Fritz Schröder; Michael W Kattan
The comparability of models for predicting the risk of a positive prostate biopsy with prostate-specific antigen alone: a systematic review.
European urology 2008;54(2):274-90.
2008: Shahrokh F Shariat; Pierre I Karakiewicz; Nazareno Suardi; Michael W Kattan
Comparison of nomograms with other methods for predicting outcomes in prostate cancer: a critical analysis of the literature.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(14):4400-7.
2008: Adrian V. Hernandez; Esteban Walker; John Ioannidis; Michael W Kattan
Challenges in meta-analysis of randomized clinical trials for rare harmful cardiovascular events: the case of rosiglitazone.
American heart journal 2008;156(1):23-30.
2008: Michael W Kattan
Do we need more nomograms for predicting outcomes in patients with prostate cancer?
Nature clinical practice. Urology 2008;5(7):366-7.
2008: Fei Dong; Michael W Kattan; Ewout W Steyerberg; J Stephen Jones; Andrew J Stephenson; Fritz H Schröder; Eric A Klein
Validation of pretreatment nomograms for predicting indolent prostate cancer: efficacy in contemporary urological practice.
The Journal of urology 2008;180(1):150-4; discussion 154.
2008: Esteban Walker; Adrian V. Hernandez; Michael W Kattan
Meta-analysis: Its strengths and limitations.
Cleveland Clinic journal of medicine 2008;75(6):431-9.
2008: Philip M Arlen; Fernando Bianco; William L Dahut; Anthony V D'Amico; William D Figg; Stephen J Freedland; James L Gulley; Philip W Kantoff; Michael W Kattan; Andrew Lee; Meredith M Regan; Oliver Sartor
Prostate Specific Antigen Working Group guidelines on prostate specific antigen doubling time.
The Journal of urology 2008;179(6):2181-5; discussion 2185-6.
2008: Ganesh V Raj; R Houston Thompson; Bradley C Leibovich; Michael L Blute; Paul Russo; Michael W Kattan
Preoperative nomogram predicting 12-year probability of metastatic renal cancer.
The Journal of urology 2008;179(6):2146-51; discussion 2151.
2008: Eric A Klein; Fernando J Bianco; Angel M Serio; James A Eastham; Michael W Kattan; J Edson Pontes; Andrew J Vickers; Peter T Scardino
Surgeon experience is strongly associated with biochemical recurrence after radical prostatectomy for all preoperative risk categories.
The Journal of urology 2008;179(6):2212-6; discussion 2216-7.
2008: James A Eastham; Peter T Scardino; Michael W Kattan
Predicting an optimal outcome after radical prostatectomy: the trifecta nomogram.
The Journal of urology 2008;179(6):2207-10; discussion 2210-1.
2008: Michael W Kattan; Mithat Gonen
The prediction philosophy in statistics.
Urologic oncology 2008;26(3):316-9.
2008: Peter Swindle; James A Eastham; Makoto Ohori; Michael W Kattan; Thomas Wheeler; Norio Maru; Kevin Slawin; Peter T Scardino
Do margins matter? The prognostic significance of positive surgical margins in radical prostatectomy specimens.
The Journal of urology 2008;179(5 Suppl):S47-51.
2008: Shahrokh F Shariat; Pierre I Karakiewicz; Vitaly Margulis; Michael W Kattan
Inventory of prostate cancer predictive tools.
Current opinion in urology 2008;18(3):279-96.
2008: Michael W Kattan
Predicting prostate cancer behavior--what is a urologist to do?
The Journal of urology 2008;179(5):1658-9.
2008: Andrew J Vickers; Fernando J Bianco; Mithat Gonen; Angel M Cronin; James A Eastham; Deborah Schrag; Eric A Klein; Alwyn M Reuther; Michael W Kattan; J Edson Pontes; Peter T Scardino
Effects of pathologic stage on the learning curve for radical prostatectomy: evidence that recurrence in organ-confined cancer is largely related to inadequate surgical technique.
European urology 2008;53(5):960-6.
2008: Andrew J Vickers; Kwang Jang; Daniel Sargent; Hans Lilja; Michael W Kattan
Systematic review of statistical methods used in molecular marker studies in cancer.
Cancer 2008;112(8):1862-8.
2008: Pierre I Karakiewicz; Naeem Bhojani; Alfred I Neugut; Shahrokh F Shariat; Claudio Jeldres; Markus Graefen; Paul Perrotte; Francois Peloquin; Michael W Kattan
The effect of comorbidity and socioeconomic status on sexual and urinary function and on general health-related quality of life in men treated with radical prostatectomy for localized prostate cancer.
The journal of sexual medicine 2008;5(4):919-27.
2008: Michael W Kattan
Nomograms are difficult to beat.
European urology 2008;53(4):671-2.
2008: Lee Richstone; Fernando J Bianco; Hiral H Shah; Michael W Kattan; James A Eastham; Peter T Scardino; Douglas Scherr
Radical prostatectomy in men aged >or=70 years: effect of age on upgrading, upstaging, and the accuracy of a preoperative nomogram.
BJU international 2008;101(5):541-6.
2008: Michael W Kattan
A nomogram for predicting 10-year life expectancy in men with prostate cancer after definitive therapy.
Nature clinical practice. Urology 2008;5(3):138-9.
2008: Clifford S Cho; Mithat Gonen; Jinru Shia; Michael W Kattan; David S Klimstra; William R Jarnagin; Michael D'Angelica; Leslie H Blumgart; Ronald P DeMatteo
A novel prognostic nomogram is more accurate than conventional staging systems for predicting survival after resection of hepatocellular carcinoma.
Journal of the American College of Surgeons 2008;206(2):281-91.
2008: Michael W Kattan; Mithat Gonen; William R Jarnagin; Ronald P DeMatteo; Michael D'Angelica; Martin R Weiser; Leslie H Blumgart; Yuman Fong
A nomogram for predicting disease-specific survival after hepatic resection for metastatic colorectal cancer.
Annals of surgery 2008;247(2):282-7.
2008: James A Eastham; Michael W Kattan; Paul Fearn; Gabrielle Fisher; Daniel M Berney; Tim Oliver; Christopher S Foster; Henrik Møller; Victor E Reuter; Jack Cuzick; Peter T Scardino
Local progression among men with conservatively treated localized prostate cancer: results from the Transatlantic Prostate Group.
European urology 2008;53(2):347-54.
2008: Martin R Weiser; Ron G Landmann; Michael W Kattan; Mithat Gonen; Jinru Shia; Joanne Chou; Philip B Paty; Jose G Guillem; Larissa K Temple; Deborah Schrag; Leonard B Saltz; Douglas Wong
Individualized prediction of colon cancer recurrence using a nomogram.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(3):380-5.
2008: W Orthuber; Gunar Fiedler; Michael W Kattan; Thorsten Sommer; Helge Fischer-Brandies
Design of a Global Medical Database which is Searchable by Human Diagnostic Patterns.
The open medical informatics journal 2008;2():21-31.
2008: Elisabeth Iljas Heath; Michael W Kattan; Isaac J Powell; Wael A Sakr; Timothy C Brand; Benjamin A Rybicki; Ian M Thompson; William J Aronson; Martha Kennedy Terris; Christopher J Kane; Joseph C Presti; Christopher L Amling; Stephen J Freedland
The effect of race/ethnicity on the accuracy of the 2001 Partin Tables for predicting pathologic stage of localized prostate cancer.
Urology 2008;71(1):151-5.
2008: Michael W Kattan; Jack Cuzick; Gabrielle Fisher; Daniel M Berney; Tim Oliver; Christopher S Foster; Henrik Møller; Victor E Reuter; Paul Fearn; James A Eastham; Peter T Scardino
Nomogram incorporating PSA level to predict cancer-specific survival for men with clinically localized prostate cancer managed without curative intent.
Cancer 2008;112(1):69-74.
2008: Dennis S Chi; Meena J Palayekar; Yukio Sonoda; Nadeem R Abu-Rustum; Christopher S Awtrey; Jae Huh; Eric L Eisenhauer; Richard R Barakat; Michael W Kattan
Nomogram for survival after primary surgery for bulky stage IIIC ovarian carcinoma.
Gynecologic oncology 2008;108(1):191-4.
2008: Eric A Klein; Michael W Kattan; Andrew Stephenson; Andrew J Vickers
How many lymphadenectomies does it take to cure one patient?
European urology 2008;53(1):13-5; discussion 18-20.
2007: Michael Lauer; Claire E Pothier; David J Magid; S Scott Smith; Michael W Kattan
An externally validated model for predicting long-term survival after exercise treadmill testing in patients with suspected coronary artery disease and a normal electrocardiogram.
Annals of internal medicine 2007;147(12):821-8.
2007: Michael W Kattan; Peter T Scardino
Evidence for the usefulness of nomograms.
Nature clinical practice. Urology 2007;4(12):638-9.
2007: Daniel M Berney; Gabrielle Fisher; Michael W Kattan; R T D Oliver; Henrik Møller; Paul Fearn; James A Eastham; Peter T Scardino; Jack Cuzick; Victor E Reuter; Christopher S Foster
Major shifts in the treatment and prognosis of prostate cancer due to changes in pathological diagnosis and grading.
BJU international 2007;100(6):1240-4.
2007: Nelson N Stone; Louis Potters; Brian J Davis; Jay P Ciezki; Michael J Zelefsky; Mack Roach; Paul Fearn; Michael W Kattan; Richard G Stock
Customized dose prescription for permanent prostate brachytherapy: insights from a multicenter analysis of dosimetry outcomes.
International journal of radiation oncology, biology, physics 2007;69(5):1472-7.
2007: Stijn Roemeling; Monique J Roobol; Michael W Kattan; Theo Van der Kwast; Ewout W Steyerberg; Fritz H Schröder
Nomogram use for the prediction of indolent prostate cancer: impact on screen-detected populations.
Cancer 2007;110(10):2218-21.
2007: Michael W Kattan
Re: Updated nomogram to predict pathologic stage of prostate cancer given prostate-specific antigen level, clinical stage, and biopsy gleason score (Partin Tables) based on cases from 2000 to 2005.
European urology 2007;52(5):1528.
2007: Michael W Kattan
Should physicians use the updated Partin tables to predict pathologic stage in patients with prostate cancer?
Nature clinical practice. Urology 2007;4(11):592-3.
2007: Fritz C Eilber; Michael W Kattan
Sarcoma nomogram: validation and a model to evaluate impact of therapy.
Journal of the American College of Surgeons 2007;205(4 Suppl):S90-5.
2007: Daniel M Berney; Gabrielle Fisher; Michael W Kattan; R T D Oliver; Henrik Møller; Paul Fearn; James A Eastham; Peter T Scardino; Jack Cuzick; Victor E Reuter; Christopher S Foster
Pitfalls in the diagnosis of prostatic cancer: retrospective review of 1791 cases with clinical outcome.
Histopathology 2007;51(4):452-7.
2007: M Scott Lucia; Jonathan I Epstein; Phyllis J Goodman; Amy K Darke; Victor E Reuter; Francisco Civantos; Catherine M Tangen; Howard L Parnes; Scott M Lippman; Francisco G La Rosa; Michael W Kattan; E David Crawford; Leslie G Ford; Charles A Coltman; Ian M Thompson
Finasteride and high-grade prostate cancer in the Prostate Cancer Prevention Trial.
Journal of the National Cancer Institute 2007;99(18):1375-83.
2007: Robert K Nam; Ants Toi; Laurence H Klotz; John Trachtenberg; Michael A S Jewett; Sree Appu; D Andrew Loblaw; Linda Sugar; Steven A Narod; Michael W Kattan
Assessing individual risk for prostate cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(24):3582-8.
2007: José Luiz B Bevilacqua; Michael W Kattan; Jane V Fey; Hiram S Cody; Patrick I Borgen; Kimberly Van Zee
Doctor, what are my chances of having a positive sentinel node? A validated nomogram for risk estimation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(24):3670-9.
2007: Michael J Zelefsky; Michael W Kattan; Paul Fearn; Bertha L Fearon; Jason Stasi; Alison M Shippy; Peter T Scardino
Pretreatment nomogram predicting ten-year biochemical outcome of three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for prostate cancer.
Urology 2007;70(2):283-7.
2007: Andrew J Vickers; Fernando J Bianco; Angel M Serio; James A Eastham; Deborah Schrag; Eric A Klein; Alwyn M Reuther; Michael W Kattan; J Edson Pontes; Peter T Scardino
The surgical learning curve for prostate cancer control after radical prostatectomy.
Journal of the National Cancer Institute 2007;99(15):1171-7.
2007: Brian R Lane; Denise Babineau; Michael W Kattan; Andrew C Novick; Inderbir S Gill; Ming Zhou; Christopher J Weight; Steven C Campbell
A preoperative prognostic nomogram for solid enhancing renal tumors 7 cm or less amenable to partial nephrectomy.
The Journal of urology 2007;178(2):429-34.
2007: Kimberly Van Zee; Michael W Kattan
Validating a predictive model for presence of additional disease in the non-sentinel lymph nodes of a woman with sentinel node positive breast cancer.
Annals of surgical oncology 2007;14(8):2177-8.
2007: Glenn Heller; Michael W Kattan; Howard I Scher
Improving the decision to pursue a phase 3 clinical trial by adjusting for patient-specific factors in evaluating phase 2 treatment efficacy data.
Medical decision making : an international journal of the Society for Medical Decision Making 2007;27(4):380-6.
2007: Inderbir S Gill; Louis R Kavoussi; Brian R Lane; Michael L Blute; Denise Babineau; Jose R Colombo; Igor Frank; Sompol Permpongkosol; Christopher J Weight; Jihad H Kaouk; Michael W Kattan; Andrew C Novick
Comparison of 1,800 laparoscopic and open partial nephrectomies for single renal tumors.
The Journal of urology 2007;178(1):41-6.
2007: Carlos Cordon-Cardo; Angeliki Kotsianti; David Verbel; Mikhail Teverovskiy; Paola Capodieci; Stefan Hamann; Yusuf Jeffers; Mark Clayton; Faysal Elkhettabi; Faisal M Khan; Marina Sapir; Valentina Bayer-Zubek; Yevgen Vengrenyuk; Stephen Fogarsi; Olivier Saidi; Victor E Reuter; Howard I Scher; Michael W Kattan; Fernando J Bianco; Thomas M Wheeler; Gustavo E Ayala; Peter T Scardino; Michael J Donovan
Improved prediction of prostate cancer recurrence through systems pathology.
The Journal of clinical investigation 2007;117(7):1876-83.
2007: Andrew J Stephenson; Peter T Scardino; Michael W Kattan; Thomas M Pisansky; Kevin Slawin; Eric A Klein; Mitchell S. Anscher; Jeff M Michalski; Howard M Sandler; Daniel W Lin; Jeffrey D Forman; Michael J Zelefsky; Larry L Kestin; Claus G Roehrborn; Charles N Catton; Theodore L DeWeese; Stanley L Liauw; Richard Valicenti; Deborah A Kuban; Alan Pollack
Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(15):2035-41.
2007: Adam S Kibel; Eli Rosenbaum; Michael W Kattan; Joel Picus; Robert Dreicer; Eric A Klein; Gurkamal S Chatta; Joel B Nelson; Robert S DiPaola; Bruce J Roth; Michael S Cookson; George Wilding; David F Jarrard; Tomasz M Beer; Christopher W Ryan; Daniel P Petrylak; Mitchell C Benson; Alan W Partin; Elizabeth Garrett-Mayer; Mario A Eisenberger
Adjuvant weekly docetaxel for patients with high risk prostate cancer after radical prostatectomy: a multi-institutional pilot study.
The Journal of urology 2007;177(5):1777-81.
2007: Felix K-H Chun; Markus Graefen; Alberto Briganti; Andrea Gallina; Julia Hopp; Michael W Kattan; Hartwig Huland; Pierre I Karakiewicz
Initial biopsy outcome prediction--head-to-head comparison of a logistic regression-based nomogram versus artificial neural network.
European urology 2007;51(5):1236-40; discussion 1241-3.
2007: Ali-Reza Golshayan; Tao Jin; Jaroslaw Maciejewski; Alex Z Fu; Boris Bershadsky; Michael W Kattan; Matt Kalaycio; Mikkael A Sekeres
Efficacy of growth factors compared to other therapies for low-risk myelodysplastic syndromes.
British journal of haematology 2007;137(2):125-32.
2007: Felix K-H Chun; Pierre I Karakiewicz; Alberto Briganti; Jochen Walz; Michael W Kattan; Hartwig Huland; Markus Graefen
A critical appraisal of logistic regression-based nomograms, artificial neural networks, classification and regression-tree models, look-up tables and risk-group stratification models for prostate cancer.
BJU international 2007;99(4):794-800.
2007: Amita Dave; Hedvig Hricak; Michael W Kattan; Darko Pucar; Kentaro Kuroiwa; Hui-Ni Chen; Jessica Spector; Jason A Koutcher; Kristen L Zakian; Peter T Scardino
The utility of magnetic resonance imaging and spectroscopy for predicting insignificant prostate cancer: an initial analysis.
BJU international 2007;99(4):786-93.
2007: Thomas Steuber; Andrew J Vickers; Alexander Haese; Michael W Kattan; James A Eastham; Peter T Scardino; Hartwig Huland; Hans Lilja
Free PSA isoforms and intact and cleaved forms of urokinase plasminogen activator receptor in serum improve selection of patients for prostate cancer biopsy.
International journal of cancer. Journal international du cancer 2007;120(7):1499-504.
2007: Mikkael A Sekeres; Alex Z Fu; Jaroslaw P Maciejewski; Ali-Reza Golshayan; Matt Kalaycio; Michael W Kattan
A Decision analysis to determine the appropriate treatment for low-risk myelodysplastic syndromes.
Cancer 2007;109(6):1125-32.
2007: Angelo Baccala; Alwyn M Reuther; Fernando J Bianco; Peter T Scardino; Michael W Kattan; Eric A Klein
Complete resection of seminal vesicles at radical prostatectomy results in substantial long-term disease-free survival: multi-institutional study of 6740 patients.
Urology 2007;69(3):536-40.
2007: David B Agus; Christopher J Sweeney; Michael J Morris; David S Mendelson; Douglas G McNeel; Frederick R Ahmann; Jin Wang; Mika K Derynck; Kimmie Ng; Benjamin Lyons; David E Allison; Michael W Kattan; Howard I Scher
Efficacy and safety of single-agent pertuzumab (rhuMAb 2C4), a human epidermal growth factor receptor dimerization inhibitor, in castration-resistant prostate cancer after progression from taxane-based therapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(6):675-81.
2007: Fernando J Bianco; Kozhaya N Mallah; Ruslan Korets; Hedvig Hricak; Peter T Scardino; Michael W Kattan
Prostate volume measured preoperatively predicts for organ-confined disease in men with clinically localized prostate cancer.
Urology 2007;69(2):343-6.
2007: Andrew J Vickers; Michael W Kattan; Sargent Daniel
Method for evaluating prediction models that apply the results of randomized trials to individual patients.
Trials 2007;8():14.
2007: Ewout W Steyerberg; Monique J Roobol; Michael W Kattan; Theo Van der Kwast; Harry J de Koning; Fritz H Schröder
Prediction of indolent prostate cancer: validation and updating of a prognostic nomogram.
The Journal of urology 2007;177(1):107-12; discussion 112.
2007: Liang Wang; Hedvig Hricak; Michael W Kattan; Hui-Ni Chen; Kentaro Kuroiwa; Halley F Eisenberg; Peter T Scardino
Prediction of seminal vesicle invasion in prostate cancer: incremental value of adding endorectal MR imaging to the Kattan nomogram.
Radiology 2007;242(1):182-8.
2006: Alex Z Fu; Michael W Kattan
Racial and ethnic differences in preference-based health status measure.
Current medical research and opinion 2006;22(12):2439-48.
2006: Mark E Snyder; Ariadne M Bach; Michael W Kattan; Ganesh V Raj; Victor E Reuter; Paul Russo
Incidence of benign lesions for clinically localized renal masses smaller than 7 cm in radiological diameter: influence of sex.
The Journal of urology 2006;176(6 Pt 1):2391-5; discussion 2395-6.
2006: Mack Roach; Vivian Weinberg; M Nash; Howard M Sandler; Patrick W McLaughlin; Michael W Kattan
Defining high risk prostate cancer with risk groups and nomograms: implications for designing clinical trials.
The Journal of urology 2006;176(6 Pt 2):S16-20.
2006: Michael W Kattan
Validating a prognostic model.
Cancer 2006;107(11):2523-4.
2006: Jack Cuzick; Gabrielle Fisher; Michael W Kattan; Daniel M Berney; T Oliver; Christopher S Foster; Henrik Møller; Victor E Reuter; Paul Fearn; James A Eastham; Peter T Scardino
Long-term outcome among men with conservatively treated localised prostate cancer.
British journal of cancer 2006;95(9):1186-94.
2006: Rebekah R White; Michael W Kattan; John C Haney; Bryan M Clary; Theodore N Pappas; Douglas S Tyler; Murray F Brennan
Evaluation of preoperative therapy for pancreatic cancer using a prognostic nomogram.
Annals of surgical oncology 2006;13(11):1485-92.
2006: Felix K-H Chun; Pierre I Karakiewicz; Alberto Briganti; Andrea Gallina; Michael W Kattan; Francesco Montorsi; Hartwig Huland; Markus Graefen
Prostate cancer nomograms: an update.
European urology 2006;50(5):914-26; discussion 926.
2006: Kimberly M Dalal; Michael W Kattan; Cristina R Antonescu; Murray F Brennan; Samuel Singer
Subtype specific prognostic nomogram for patients with primary liposarcoma of the retroperitoneum, extremity, or trunk.
Annals of surgery 2006;244(3):381-91.
2006: Andrew J Stephenson; Michael W Kattan; James A Eastham; Zohar A Dotan; Fernando J Bianco; Hans Lilja; Peter T Scardino
Defining biochemical recurrence of prostate cancer after radical prostatectomy: a proposal for a standardized definition.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(24):3973-8.
2006: Bernard H Bochner; Michael W Kattan; Kinjal C Vora
Postoperative nomogram predicting risk of recurrence after radical cystectomy for bladder cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(24):3967-72.
2006: Elena B Elkin; Andrew J Vickers; Michael W Kattan
Primer: using decision analysis to improve clinical decision making in urology.
Nature clinical practice. Urology 2006;3(8):439-48.
2006: Maximiliano Sorbellini; Michael W Kattan; Mark E Snyder; A Ari Hakimi; Debra M Sarasohn; Paul Russo
Prognostic nomogram for renal insufficiency after radical or partial nephrectomy.
The Journal of urology 2006;176(2):472-6; discussion 476.
2006: Lee R Schachter; Ariadne M Bach; Mark E Snyder; Michael W Kattan; Paul Russo
The impact of tumour location on the histological subtype of renal cortical tumours.
BJU international 2006;98(1):63-6.
2006: Andrew J Stephenson; Michael W Kattan
Nomograms for prostate cancer.
BJU international 2006;98(1):39-46.
2006: Alvaro Ramirez; Serge Benayoun; Alberto Briganti; Jongi Chun; Paul Perrotte; Michael W Kattan; Markus Graefen; Michael McCormack; Alfred I Neugut; Fred Saad; Pierre I Karakiewicz
High radical prostatectomy surgical volume is related to lower radical prostatectomy total hospital charges.
European urology 2006;50(1):58-62; discussion 62-3.
2006: Nicolas Mottet; Tommaso Prayer-Galetti; Peter Hammerer; Michael W Kattan; Ulf Tunn
Optimizing outcomes and quality of life in the hormonal treatment of prostate cancer.
BJU international 2006;98(1):20-7.
2006: Peter Hammerer; Michael W Kattan; Nicolas Mottet; Tommaso Prayer-Galetti
Using prostate-specific antigen screening and nomograms to assess risk and predict outcomes in the management of prostate cancer.
BJU international 2006;98(1):11-9.
2006: Michael W Kattan; Vincenzo Ficarra; Walter Artibani; Sergio Cosciani Cunico; Andrea Fandella; Guido Martignoni; Giacomo Novara; Tommaso Prayer Galetti; Filiberto Zattoni
Nomogram predictive of cancer specific survival in patients undergoing partial or total amputation for squamous cell carcinoma of the penis.
The Journal of urology 2006;175(6):2103-8; discussion 2108.
2006: Bin S Teh; Michael D Bastasch; Wei-Yuan Mai; Michael W Kattan; E. Brian Butler; Dov Kadmon
Long-term benefits of elective radiotherapy after prostatectomy for patients with positive surgical margins.
The Journal of urology 2006;175(6):2097-101; discussion 2101-2.
2006: Andrew J Stephenson; Peter T Scardino; James A Eastham; Fernando J Bianco; Zohar A Dotan; Paul Fearn; Michael W Kattan
Preoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy.
Journal of the National Cancer Institute 2006;98(10):715-7.
2006: Vincenzo Ficarra; Filiberto Zattoni; Walter Artibani; Andrea Fandella; Guido Martignoni; Giacomo Novara; Tommaso Prayer Galetti; Tiziano Zambolin; Michael W Kattan
Nomogram predictive of pathological inguinal lymph node involvement in patients with squamous cell carcinoma of the penis.
The Journal of urology 2006;175(5):1700-4; discussion 1704-5.
2006: Eric D Hixson; Michael W Kattan
Nomograms are more meaningful than severity-adjusted institutional comparisons for reporting outcomes.
European urology 2006;49(4):600-3.
2006: Liang Wang; Hedvig Hricak; Michael W Kattan; Lawrence H Schwartz; Steven C Eberhardt; Hui-Ni Chen; Peter T Scardino
Combined endorectal and phased-array MRI in the prediction of pelvic lymph node metastasis in prostate cancer.
AJR. American journal of roentgenology 2006;186(3):743-8.
2006: Ernesto Lopez-Corona; Makoto Ohori; Thomas M Wheeler; Victor E Reuter; Peter T Scardino; Michael W Kattan; James A Eastham
Prostate cancer diagnosed after repeat biopsies have a favorable pathological outcome but similar recurrence rate.
The Journal of urology 2006;175(3 Pt 1):923-7; discussion 927-8.
2006: Thomas Steuber; Andrew J Vickers; Alexander Haese; Charlotte Becker; Kim Pettersson; Felix K-H Chun; Michael W Kattan; James A Eastham; Peter T Scardino; Hartwig Huland; Hans Lilja
Risk assessment for biochemical recurrence prior to radical prostatectomy: significant enhancement contributed by human glandular kallikrein 2 (hK2) and free prostate specific antigen (PSA) in men with moderate PSA-elevation in serum.
International journal of cancer. Journal international du cancer 2006;118(5):1234-40.
2006: Michael W Kattan
Measuring hot flashes in men treated with hormone ablation therapy: an unmet need.
Urologic nursing 2006;26(1):13-8.
2006: Liang Wang; Hedvig Hricak; Michael W Kattan; Hui-Ni Chen; Peter T Scardino; Kentaro Kuroiwa
Prediction of organ-confined prostate cancer: incremental value of MR imaging and MR spectroscopic imaging to staging nomograms.
Radiology 2006;238(2):597-603.
2006: Kevin Slawin; Michael W Kattan; Claus G Roehrborn; Timothy Wilson
Development of nomogram to predict acute urinary retention or surgical intervention, with or without dutasteride therapy, in men with benign prostatic hyperplasia.
Urology 2006;67(1):84-8.
2006: Mark E Cowen; Lakshmi K Halasyamani; Michael W Kattan
Predicting life expectancy in men with clinically localized prostate cancer.
The Journal of urology 2006;175(1):99-103.
2006: Alexander R Novotny; Christoph Schuhmacher; Raymonde Busch; Michael W Kattan; Murray F Brennan; Jörg Rüdiger Siewert
Predicting individual survival after gastric cancer resection: validation of a U.S.-derived nomogram at a single high-volume center in Europe.
Annals of surgery 2006;243(1):74-81.
2005: Toshiki Tsuboi; Makoto Ohori; Kentaro Kuroiwa; Victor E Reuter; Michael W Kattan; James A Eastham; Peter T Scardino
Is intraoperative frozen section analysis an efficient way to reduce positive surgical margins?
Urology 2005;66(6):1287-91.
2005: Pierre I Karakiewicz; James A Eastham; Markus Graefen; Ilias Cagiannos; Phillip D Stricker; Eric Klein; Thomas Cangiano; Fritz H Schröder; Peter T Scardino; Michael W Kattan
Prognostic impact of positive surgical margins in surgically treated prostate cancer: multi-institutional assessment of 5831 patients.
Urology 2005;66(6):1245-50.
2005: Michael Mullerad; Hedvig Hricak; Kentaro Kuroiwa; Darko Pucar; Hui-Ni Chen; Michael W Kattan; Peter T Scardino
Comparison of endorectal magnetic resonance imaging, guided prostate biopsy and digital rectal examination in the preoperative anatomical localization of prostate cancer.
The Journal of urology 2005;174(6):2158-63.
2005: Cristina R Ferrone; Michael W Kattan; James Tomlinson; Sarah P Thayer; Murray F Brennan; Andrew L Warshaw
Validation of a postresection pancreatic adenocarcinoma nomogram for disease-specific survival.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(30):7529-35.
2005: Ethan M Katz; Michael W Kattan
How to judge a tumor marker.
Nature clinical practice. Oncology 2005;2(10):482-3.
2005: Andrew J Stephenson; Peter T Scardino; James A Eastham; Fernando J Bianco; Zohar A Dotan; Christopher J DiBlasio; Alwyn M Reuther; Eric A Klein; Michael W Kattan
Postoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(28):7005-12.
2005: Christie Befort; Michael J Zelefsky; Peter T Scardino; Evelinn Borrayo; R Brian Giesler; Michael W Kattan
A measure of health-related quality of life among patients with localized prostate cancer: results from ongoing scale development.
Clinical prostate cancer 2005;4(2):100-8.
2005: Peter Swindle; James A Eastham; Makoto Ohori; Michael W Kattan; Thomas Wheeler; Norio Maru; Kevin Slawin; Peter T Scardino
Do margins matter? The prognostic significance of positive surgical margins in radical prostatectomy specimens.
The Journal of urology 2005;174(3):903-7.
2005: Brian R Lane; Michael W Kattan
Predicting outcomes in renal cell carcinoma.
Current opinion in urology 2005;15(5):289-97.
2005: Michelle C Specht; Michael W Kattan; Mithat Gonen; Jane V Fey; Kimberly Van Zee
Predicting nonsentinel node status after positive sentinel lymph biopsy for breast cancer: clinicians versus nomogram.
Annals of surgical oncology 2005;12(8):654-9.
2005: Michael Mullerad; Bernard H Bochner; Prasad S Adusumilli; Amit Bhargava; Eiji Kikuchi; Chen Hui-Ni; Michael W Kattan; Ting-Chao Chou; Yuman Fong
Herpes simplex virus based gene therapy enhances the efficacy of mitomycin C for the treatment of human bladder transitional cell carcinoma.
The Journal of urology 2005;174(2):741-6.
2005: Andrew J Stephenson; Alex Smith; Michael W Kattan; Jaya M Satagopan; Victor E Reuter; Peter T Scardino; William L Gerald
Integration of gene expression profiling and clinical variables to predict prostate carcinoma recurrence after radical prostatectomy.
Cancer 2005;104(2):290-8.
2005: Jeffery W Saranchuk; Michael W Kattan; Elena B Elkin; A Karim Touijer; Peter T Scardino; James A Eastham
Achieving optimal outcomes after radical prostatectomy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(18):4146-51.
2005: Fernando J Bianco; Elyn Riedel; Colin B Begg; Michael W Kattan; Peter T Scardino
Variations among high volume surgeons in the rate of complications after radical prostatectomy: further evidence that technique matters.
The Journal of urology 2005;173(6):2099-103.
2005: Ginger Isom-Batz; Fernando J Bianco; Michael W Kattan; John P Mulhall; Hans Lilja; James A Eastham
Testosterone as a predictor of pathological stage in clinically localized prostate cancer.
The Journal of urology 2005;173(6):1935-7.
2005: Pierre I Karakiewicz; Serge Benayoun; Michael W Kattan; Paul Perrotte; Luc Valiquette; Peter T Scardino; Ilias Cagiannos; Hans Heinzer; Simon Tanguay; Armen G Aprikian; Hartwig Huland; Markus Graefen
Development and validation of a nomogram predicting the outcome of prostate biopsy based on patient age, digital rectal examination and serum prostate specific antigen.
The Journal of urology 2005;173(6):1930-4.
2005: Kozhaya N Mallah; Christopher J DiBlasio; Audrey C Rhee; Peter T Scardino; Michael W Kattan
Body mass index is weakly associated with, and not a helpful predictor of, disease progression in men with clinically localized prostate carcinoma treated with radical prostatectomy.
Cancer 2005;103(10):2030-4.
2005: Andrew J Stephenson; George J Bosl; Robert J Motzer; Michael W Kattan; Jason Stasi; Dean F Bajorin; Joel Sheinfeld
Retroperitoneal lymph node dissection for nonseminomatous germ cell testicular cancer: impact of patient selection factors on outcome.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(12):2781-8.
2005: Michael W Kattan
When and how to use informatics tools in caring for urologic patients.
Nature clinical practice. Urology 2005;2(4):183-90.
2005: Sandra L Wong; Michael W Kattan; Kelly M McMasters; Daniel G Coit
A nomogram that predicts the presence of sentinel node metastasis in melanoma with better discrimination than the American Joint Committee on Cancer staging system.
Annals of surgical oncology 2005;12(4):282-8.
2005: Thomas Steuber; Pauliina Niemela; Alexander Haese; Kim Pettersson; Andreas Erbersdobler; K-H Felix Chun; Markus Graefen; Michael W Kattan; Hartwig Huland; Hans Lilja
Association of free-prostate specific antigen subfractions and human glandular kallikrein 2 with volume of benign and malignant prostatic tissue.
The Prostate 2005;63(1):13-8.
2005: Zohar A Dotan; Fernando J Bianco; Farhang Rabbani; James A Eastham; Paul Fearn; Howard I Scher; Kevin W Kelly; Hui-Ni Chen; Heiko Schöder; Hedvig Hricak; Peter T Scardino; Michael W Kattan
Pattern of prostate-specific antigen (PSA) failure dictates the probability of a positive bone scan in patients with an increasing PSA after radical prostatectomy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(9):1962-8.
2005: Kristen L Zakian; Kanishka Sircar; Hedvig Hricak; Hui-Ni Chen; Amita Dave; Steven C Eberhardt; Manickam Muruganandham; Lanie Ebora; Michael W Kattan; Victor E Reuter; Peter T Scardino; Jason A Koutcher
Correlation of proton MR spectroscopic imaging with gleason score based on step-section pathologic analysis after radical prostatectomy.
Radiology 2005;234(3):804-14.
2005: Alexander Haese; Ville Vaisanen; Hans Lilja; Michael W Kattan; Harry G Rittenhouse; Kim Pettersson; Daniel W Chan; Hartwig Huland; Lori J Sokoll; Alan W Partin
Comparison of predictive accuracy for pathologically organ confined clinical stage T1c prostate cancer using human glandular kallikrein 2 and prostate specific antigen combined with clinical stage and Gleason grade.
The Journal of urology 2005;173(3):752-6.
2005: Brett S Carver; Michael W Kattan; Peter T Scardino; James A Eastham
Gleason grade remains an important prognostic predictor in men diagnosed with prostate cancer while on finasteride therapy.
BJU international 2005;95(4):509-12.
2005: K C M J Peeters; Michael W Kattan; Henk H Hartgrink; Elma Klein Kranenbarg; Martin S Karpeh; Murray F Brennan; Cornelis J H van de Velde
Validation of a nomogram for predicting disease-specific survival after an R0 resection for gastric carcinoma.
Cancer 2005;103(4):702-7.
2005: Brent V Yanke; Mithat Gonen; Peter T Scardino; Michael W Kattan
Validation of a nomogram for predicting positive repeat biopsy for prostate cancer.
The Journal of urology 2005;173(2):421-4.
2005: Luigi Mariani; Rosalba Miceli; Michael W Kattan; Murray F Brennan; Maurizio Colecchia; Marco Fiore; Paolo G Casali; Alessandro Gronchi
Validation and adaptation of a nomogram for predicting the survival of patients with extremity soft tissue sarcoma using a three-grade system.
Cancer 2005;103(2):402-8.
2005: Maximiliano Sorbellini; Michael W Kattan; Mark E Snyder; Victor E Reuter; Robert J Motzer; Manlio Goetzl; James M McKiernan; Paul Russo
A postoperative prognostic nomogram predicting recurrence for patients with conventional clear cell renal cell carcinoma.
The Journal of urology 2005;173(1):48-51.
2004: Peter B Bach; Elena B Elkin; Ugo Pastorino; Michael W Kattan; Alvin I Mushlin; Colin B Begg; D Maxwell Parkin
Benchmarking lung cancer mortality rates in current and former smokers.
Chest 2004;126(6):1742-9.
2004: Michael Mullerad; Paul Russo; Dragan Golijanin; Hui-Ni Chen; Harold H Tsai; S Machele Donat; Bernard H Bochner; Harry W Herr; Joel Sheinfeld; Pramod C Sogani; Michael W Kattan; Guido Dalbagni
Bladder cancer as a prognostic factor for upper tract transitional cell carcinoma.
The Journal of urology 2004;172(6 Pt 1):2177-81.
2004: Michael W Kattan; Dilip D Giri; Katherine S Panageas; Amanda J Hummer; Milicent Cranor; Kimberly Van Zee; Clifford Hudis; Larry Norton; Patrick I Borgen; Lee K Tan
A tool for predicting breast carcinoma mortality in women who do not receive adjuvant therapy.
Cancer 2004;101(11):2509-15.
2004: Fritz C Eilber; Murray F Brennan; Frederick R Eilber; Sarah M Dry; Samuel Singer; Michael W Kattan
Validation of the postoperative nomogram for 12-year sarcoma-specific mortality.
Cancer 2004;101(10):2270-5.
2004: Brett S Carver; Caleb B Bozeman; Walter J Simoneaux; Dennis D Venable; Michael W Kattan; James A Eastham
Race is not a predictor of prostate cancer detection on repeat prostate biopsy.
The Journal of urology 2004;172(5 Pt 1):1853-5.
2004: Fernando J Bianco; Michael W Kattan; Peter T Scardino
PSA velocity and prostate cancer.
The New England journal of medicine 2004;351(17):1800-2; author reply 1800-2.
2004: Bernard H Bochner; Daniel Cho; Harry W Herr; S Machele Donat; Michael W Kattan; Guido Dalbagni
Prospectively packaged lymph node dissections with radical cystectomy: evaluation of node count variability and node mapping.
The Journal of urology 2004;172(4 Pt 1):1286-90.
2004: Fernando P Secin; Brett S Carver; Michael W Kattan; James A Eastham
Current recommendations for delaying renal transplantation after localized prostate cancer treatment: are they still appropriate?
Transplantation 2004;78(5):710-2.
2004: Elena B Elkin; Mark E Cowen; Daniel Cahill; Mary Steffel; Michael W Kattan
Preference assessment method affects decision-analytic recommendations: a prostate cancer treatment example.
Medical decision making : an international journal of the Society for Medical Decision Making 2004;24(5):504-10.
2004: Murray F Brennan; Michael W Kattan; David S Klimstra; Kevin Conlon
Prognostic nomogram for patients undergoing resection for adenocarcinoma of the pancreas.
Annals of surgery 2004;240(2):293-8.
2004: Pierre I Karakiewicz; Simon Tanguay; Michael W Kattan; Mostafa Elhilali; Armen G Aprikian
Erectile and urinary dysfunction after radical prostatectomy for prostate cancer in Quebec: a population-based study of 2415 men.
European urology 2004;46(2):188-94.
2004: Michael W Kattan; Andrew J Vickers
Incorporating predictions of individual patient risk in clinical trials.
Urologic oncology 2004;22(4):348-52.
2004: Liang Wang; Michael Mullerad; Hui-Ni Chen; Steven C Eberhardt; Michael W Kattan; Peter T Scardino; Hedvig Hricak
Prostate cancer: incremental value of endorectal MR imaging findings for prediction of extracapsular extension.
Radiology 2004;232(1):133-9.
2004: Michael Mullerad; Hedvig Hricak; Liang Wang; Hui-Ni Chen; Michael W Kattan; Peter T Scardino
Prostate cancer: detection of extracapsular extension by genitourinary and general body radiologists at MR imaging.
Radiology 2004;232(1):140-6.
2004: Hedvig Hricak; Liang Wang; David C Wei; Fergus V Coakley; Oguz Akin; Victor E Reuter; Mithat Gonen; Michael W Kattan; Chinyere N Onyebuchi; Peter T Scardino
The role of preoperative endorectal magnetic resonance imaging in the decision regarding whether to preserve or resect neurovascular bundles during radical retropubic prostatectomy.
Cancer 2004;100(12):2655-63.
2004: Herb Singh; Pierre I Karakiewicz; Shahrokh F Shariat; Eduardo I Canto; Rahul K Nath; Michael W Kattan; Kevin Slawin
Impact of unilateral interposition sural nerve grafting on recovery of urinary function after radical prostatectomy.
Urology 2004;63(6):1122-7.
2004: Kirsten L Greene; Maxwell V Meng; Eric P Elkin; Matthew Cooperberg; David J Pasta; Michael W Kattan; Katrine Wallace; Peter R Carroll
Validation of the Kattan preoperative nomogram for prostate cancer recurrence using a community based cohort: results from cancer of the prostate strategic urological research endeavor (capsure).
The Journal of urology 2004;171(6 Pt 1):2255-9.
2004: Makoto Ohori; Michael W Kattan; Hideshige Koh; Norio Maru; Kevin Slawin; Shahrokh F Shariat; Masatoshi Muramoto; Victor E Reuter; Thomas M Wheeler; Peter T Scardino
Predicting the presence and side of extracapsular extension: a nomogram for staging prostate cancer.
The Journal of urology 2004;171(5):1844-9; discussion 1849.
2004: Laurent Boccon-Gibod; W B Djavan; Peter Hammerer; W Hoeltl; Michael W Kattan; Tommaso Prayer-Galetti; P Teillac; Ulf Tunn
Management of prostate-specific antigen relapse in prostate cancer: a European Consensus.
International journal of clinical practice 2004;58(4):382-90.
2004: Louis Potters; Eric A Klein; Michael W Kattan; Chandana A Reddy; Jay P Ciezki; Alwyn M Reuther; Patrick A Kupelian
Monotherapy for stage T1-T2 prostate cancer: radical prostatectomy, external beam radiotherapy, or permanent seed implantation.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2004;71(1):29-33.
2004: Andrew J Stephenson; Shahrokh F Shariat; Michael J Zelefsky; Michael W Kattan; E. Brian Butler; Bin S Teh; Eric A Klein; Patrick A Kupelian; Claus G Roehrborn; David A Pistenmaa; Heather D Pacholke; Stanley L Liauw; Matthew Katz; Steven A Leibel; Peter T Scardino; Kevin Slawin
Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy.
JAMA : the journal of the American Medical Association 2004;291(11):1325-32.
2004: Shahrokh F Shariat; Michael W Kattan; Erica Traxel; Ben Andrews; Kuichun Zhu; Thomas M Wheeler; Kevin Slawin
Association of pre- and postoperative plasma levels of transforming growth factor beta(1) and interleukin 6 and its soluble receptor with prostate cancer progression.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(6):1992-9.
2004: Christopher J DiBlasio; Mark E Snyder; Michael W Kattan; Paul Russo
Ketorolac: safe and effective analgesia for the management of renal cortical tumors with partial nephrectomy.
The Journal of urology 2004;171(3):1062-5.
2004: Makoto Ohori; Michael W Kattan; Peter T Scardino; Thomas M Wheeler
Radical prostatectomy for carcinoma of the prostate.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2004;17(3):349-59.
2004: Michael W Kattan
Evaluating a new marker's predictive contribution.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(3):822-4.
2004: Howard I Scher; Mario A Eisenberger; Anthony V D'Amico; Susan Halabi; Eric J Small; Michael J Morris; Michael W Kattan; Mack Roach; Philip W Kantoff; Kenneth J Pienta; Michael A Carducci; David B Agus; Susan F Slovin; Glenn Heller; W Kevin Kelly; Paul H Lange; Daniel P Petrylak; William Berg; Celestia S Higano; George Wilding; Judd W Moul; Alan W Partin; Christopher Logothetis; Howard R Soule
Eligibility and outcomes reporting guidelines for clinical trials for patients in the state of a rising prostate-specific antigen: recommendations from the Prostate-Specific Antigen Working Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(3):537-56.
2004: Jim C Hu; Eric P Elkin; David J Pasta; Deborah P Lubeck; Michael W Kattan; Peter R Carroll; Mark S Litwin
Predicting quality of life after radical prostatectomy: results from CaPSURE.
The Journal of urology 2004;171(2 Pt 1):703-7; discussion 707-8.
2004: Ilias Cagiannos; Pierre I Karakiewicz; Markus Graefen; James A Eastham; Makoto Ohori; Farhang Rabbani; Victor E Reuter; Thomas Wheeler; Patrick A Kupelian; Eric Klein; Hartwig Huland; Peter Hammerer; Andreas Erbersdobler; Fritz Schroeder; Mark F Wildhagen; David I Quinn; Susan M Henshall; John J Grygiel; Robert L Sutherland; Phillip D Stricker; Christopher G Morash; Peter T Scardino; Michael W Kattan
Is year of radical prostatectomy a predictor of outcome in prostate cancer?
The Journal of urology 2004;171(2 Pt 1):692-6.
2004: Lee Richstone; Douglas Scherr; Victor R Reuter; Mark E Snyder; Farhang Rabbani; Michael W Kattan; Paul Russo
Multifocal renal cortical tumors: frequency, associated clinicopathological features and impact on survival.
The Journal of urology 2004;171(2 Pt 1):615-20.
2004: Kevin Slawin; Michael W Kattan
The Use of Nomograms for Selecting BPH Candidates for Dutasteride Therapy.
Reviews in urology 2004;6 Suppl 9():S40-5.
2004: Kevin Slawin; Christopher J DiBlasio; Michael W Kattan
Minimally Invasive Therapy for Prostate Cancer: Use of Nomograms to Counsel Patients about the Choice and Probable Outcome of Therapy.
Reviews in urology 2004;6 Suppl 4():S3-8.
2004: Shahrokh F Shariat; Eduardo I Canto; Michael W Kattan; Kevin Slawin
Beyond prostate-specific antigen: new serologic biomarkers for improved diagnosis and management of prostate cancer.
Reviews in urology 2004;6(2):58-72.
2004: Stephen D W Beck; Manish I Patel; Mark E Snyder; Michael W Kattan; Robert J Motzer; Victor E Reuter; Paul Russo
Effect of papillary and chromophobe cell type on disease-free survival after nephrectomy for renal cell carcinoma.
Annals of surgical oncology 2004;11(1):71-7.
2004: Markus Graefen; Makoto Ohori; Pierre I Karakiewicz; Ilias Cagiannos; Peter Hammerer; Alexander Haese; Andreas Erbersdobler; Rolf-Peter Henke; Hartwig Huland; Thomas M Wheeler; Kevin Slawin; Peter T Scardino; Michael W Kattan
Assessment of the enhancement in predictive accuracy provided by systematic biopsy in predicting outcome for clinically localized prostate cancer.
The Journal of urology 2004;171(1):200-3.
2003: Christopher J DiBlasio; Michael W Kattan
Use of nomograms to predict the risk of disease recurrence after definitive local therapy for prostate cancer.
Urology 2003;62 Suppl 1():9-18.
2003: Michael W Kattan; Michael J Zelefsky; Patrick A Kupelian; Daniel Cho; Peter T Scardino; Zvi Fuks; Steven A Leibel
Pretreatment nomogram that predicts 5-year probability of metastasis following three-dimensional conformal radiation therapy for localized prostate cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(24):4568-71.
2003: Michael W Kattan
Comparing treatment outcomes using utility assessment for health-related quality of life.
Oncology (Williston Park, N.Y.) 2003;17(12):1687-93; discussion 1693-4, 1697, 1701.
2003: Louis Potters; David Huang; Emel Calugaru; Paul Fearn; Lucille Lee; Michael W Kattan
Importance of implant dosimetry for patients undergoing prostate brachytherapy.
Urology 2003;62(6):1073-7.
2003: Kimberly Van Zee; Donna-Marie E Manasseh; José Luiz B Bevilacqua; Susan Boolbol; Jane V Fey; Lee K Tan; Patrick I Borgen; Hiram S Cody; Michael W Kattan
A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy.
Annals of surgical oncology 2003;10(10):1140-51.
2003: James A Eastham; Michael W Kattan; Elyn Riedel; Colin B Begg; Thomas M Wheeler; Claudia Gerigk; Mithat Gonen; Victor E Reuter; Peter T Scardino
Variations among individual surgeons in the rate of positive surgical margins in radical prostatectomy specimens.
The Journal of urology 2003;170(6 Pt 1):2292-5.
2003: Michael W Kattan
Comparison of Cox regression with other methods for determining prediction models and nomograms.
The Journal of urology 2003;170(6 Pt 2):S6-9; discussion S10.
2003: Peter R Carroll; David A Benaron; George Blackledge; Fergus V Coakley; Anthony V D'amico; Celestia S Higano; Peter Iversen; Michael W Kattan; David M Nanus; Joel B Nelson; William K Oh; Mack Roach; William R Sellers; Matthew R Smith; Mary Carole McMann; Philip W Kantoff
Third international conference on innovations and challenges in prostate cancer: prevention, detection and treatment.
The Journal of urology 2003;170(6 Pt 2):S3-5.
2003: Michael W Kattan; Glenn Heller; Murray F Brennan
A competing-risks nomogram for sarcoma-specific death following local recurrence.
Statistics in medicine 2003;22(22):3515-25.
2003: Benjamin Littenberg; Steven Partilo; Anita Licata; Michael W Kattan
Paper Standard Gamble: the reliability of a paper questionnaire to assess utility.
Medical decision making : an international journal of the Society for Medical Decision Making 2003;23(6):480-8.
2003: David B Solit; Michael J Morris; Susan F Slovin; Tracy Curley; Lawrence H Schwartz; Steven M Larson; Michael W Kattan; Beryl Hartley-Asp; Howard I Scher; W Kevin Kelly
Clinical experience with intravenous estramustine phosphate, paclitaxel, and carboplatin in patients with castrate, metastatic prostate adenocarcinoma.
Cancer 2003;98(9):1842-8.
2003: Ilias Cagiannos; Pierre I Karakiewicz; James A Eastham; Makoto Ohori; Farhang Rabbani; Claudia Gerigk; Victor E Reuter; Markus Graefen; Peter Hammerer; Andreas Erbersdobler; Hartwig Huland; Patrick A Kupelian; Eric Klein; David I Quinn; Susan M Henshall; John J Grygiel; Robert L Sutherland; Phillip D Stricker; Christopher G Morash; Peter T Scardino; Michael W Kattan
A preoperative nomogram identifying decreased risk of positive pelvic lymph nodes in patients with prostate cancer.
The Journal of urology 2003;170(5):1798-803.
2003: Michael W Kattan; James A Eastham; Thomas M Wheeler; Norio Maru; Peter T Scardino; Andreas Erbersdobler; Markus Graefen; Hartwig Huland; Hideshige Koh; Shahrokh F Shariat; Kevin Slawin; Makoto Ohori
Counseling men with prostate cancer: a nomogram for predicting the presence of small, moderately differentiated, confined tumors.
The Journal of urology 2003;170(5):1792-7.
2003: Michael W Kattan; Peter T Scardino
Prostate cancer: nomograms and risk assessment models.
Journal of the National Comprehensive Cancer Network : JNCCN 2003;1 Suppl 3():S-49-54.
2003: Christopher J Di Blasio; Audrey C Rhee; Daniel Cho; Peter T Scardino; Michael W Kattan
Predicting clinical end points: treatment nomograms in prostate cancer.
Seminars in oncology 2003;30(5):567-86.
2003: Michael W Kattan; Martin S Karpeh; Madhu Mazumdar; Murray F Brennan
Postoperative nomogram for disease-specific survival after an R0 resection for gastric carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(19):3647-50.
2003: Hideshige Koh; Michael W Kattan; Peter T Scardino; Kazuho Suyama; Norio Maru; Kevin Slawin; Thomas M Wheeler; Makoto Ohori
A nomogram to predict seminal vesicle invasion by the extent and location of cancer in systematic biopsy results.
The Journal of urology 2003;170(4 Pt 1):1203-8.
2003: Ernesto Lopez-Corona; Makoto Ohori; Peter T Scardino; Victor E Reuter; Mithat Gonen; Michael W Kattan
A nomogram for predicting a positive repeat prostate biopsy in patients with a previous negative biopsy session.
The Journal of urology 2003;170(4 Pt 1):1184-8; discussion 1188.
2003: Kristen L Zakian; Steven C Eberhardt; Hedvig Hricak; Amita Dave; Shanon Kleinman; Manickam Muruganandham; Kanishka Sircar; Michael W Kattan; Victor E Reuter; Peter T Scardino; Jason A Koutcher
Transition zone prostate cancer: metabolic characteristics at 1H MR spectroscopic imaging--initial results.
Radiology 2003;229(1):241-7.
2003: Michael W Kattan; Shahrokh F Shariat; Ben Andrews; Kuichun Zhu; Eduardo I Canto; Kazumasa Matsumoto; Masatoshi Muramoto; Peter T Scardino; Makoto Ohori; Thomas M Wheeler; Kevin Slawin
The addition of interleukin-6 soluble receptor and transforming growth factor beta1 improves a preoperative nomogram for predicting biochemical progression in patients with clinically localized prostate cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(19):3573-9.
2003: Shahrokh F Shariat; Michael W Kattan; Weitao Song; David Bernard; Emanuel Gottenger; Thomas M Wheeler; Kevin Slawin
Early postoperative peripheral blood reverse transcription PCR assay for prostate-specific antigen is associated with prostate cancer progression in patients undergoing radical prostatectomy.
Cancer research 2003;63(18):5874-8.
2003: Shahrokh F Shariat; Martine P Roudier; George E Wilcox; Michael W Kattan; Peter T Scardino; Robert L Vessella; Sibel Erdamar; Cuong Nguyen; Thomas M Wheeler; Kevin Slawin
Comparison of immunohistochemistry with reverse transcription-PCR for the detection of micrometastatic prostate cancer in lymph nodes.
Cancer research 2003;63(15):4662-70.
2003: Louis Potters; Michael W Kattan; Paul Fearn
A chronological database to support outcomes research in prostate cancer.
International journal of radiation oncology, biology, physics 2003;56(5):1252-8.
2003: Daniel Cho; Christopher J Di Blasio; Audrey C Rhee; Michael W Kattan
Prognostic factors for survival in patients with hormone-refractory prostate cancer (HRPC) after initial androgen deprivation therapy (ADT).
Urologic oncology 2003;21(4):282-91.
2003: Michael Aleman; Pierre I Karakiewicz; Patrick A Kupelian; Michael W Kattan; Markus Graefen; Ilias Cagiannos; James A Eastham; Peter T Scardino; Hartwig Huland; Eric A Klein
Age and PSA predict likelihood of organ-confined disease in men presenting with PSA less than 10 ng/mL: implications for screening.
Urology 2003;62(1):70-4.
2003: Fernando J Bianco; Michael W Kattan; Peter T Scardino; Isaac J Powell; J Edson Pontes; David P Wood Jr
Radical prostatectomy nomograms in black American men: accuracy and applicability.
The Journal of urology 2003;170(1):73-6; discussion 76-7.
2003: Louis Potters; Rosemary Purrazzella; Sheryl Brustein; Paul Fearn; David Huang; Steven A Leibel; Michael W Kattan
The prognostic significance of Gleason Grade in patients treated with permanent prostate brachytherapy.
International journal of radiation oncology, biology, physics 2003;56(3):749-54.
2003: Ofer Yossepowitch; Edouard J Trabulsi; Michael W Kattan; Peter T Scardino
Predictive factors in prostate cancer: implications for decision making.
Cancer investigation 2003;21(3):465-80.
2003: Michael W Kattan
Judging new markers by their ability to improve predictive accuracy.
Journal of the National Cancer Institute 2003;95(9):634-5.
2003: Cheryl T Lee; Elizabeth M Genega; Brian Hutchinson; Paul A Fearn; Michael W Kattan; Paul Russo; Victor E Reuter
Conventional (clear cell) renal carcinoma metastases have greater bcl-2 expression than high-risk primary tumors.
Urologic oncology 2003;21(3):179-84.
2003: Markus Graefen; Herbert Augustin; P I Karakiewicz; Peter Hammerer; Alexander Haese; Jüri Palisaar; S Fernandez; Joachim Noldus; Andreas Erbersdobler; Ilias Cagiannos; Peter T Scardino; Michael W Kattan; Hartwig Huland
[Can nomograms derived in the U.S. applied to German patients? A study about the validation of preoperative nomograms predicting the risk of recurrence after radical prostatectomy].
Der Urologe. Ausg. A 2003;42(5):685-92.
2003: Manish I Patel; Rachel Simmons; Michael W Kattan; Robert J Motzer; Victor E Reuter; Paul Russo
Long-term follow-up of bilateral sporadic renal tumors.
Urology 2003;61(5):921-5.
2003: Peter W Swindle; Michael W Kattan; Peter T Scardino
Markers and meaning of primary treatment failure.
The Urologic clinics of North America 2003;30(2):377-401.
2003: Susan Halabi; Eric J Small; Philip W Kantoff; Michael W Kattan; Ellen B Kaplan; Nancy A Dawson; Ellis G Levine; Brent A Blumenstein; Nicholas J Vogelzang
Prognostic model for predicting survival in men with hormone-refractory metastatic prostate cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(7):1232-7.
2003: Shahrokh F Shariat; Michael W Kattan; Sibel Erdamar; Cuong Nguyen; Peter T Scardino; David M Spencer; Thomas M Wheeler; Kevin Slawin
Detection of clinically significant, occult prostate cancer metastases in lymph nodes using a splice variant-specific rt-PCR assay for human glandular kallikrein.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(7):1223-31.
2003: Peter B Bach; Michael W Kattan; Mark D Thornquist; Mark G Kris; Ramsey C Tate; Matt J Barnett; Lillian J Hsieh; Colin B Begg
Variations in lung cancer risk among smokers.
Journal of the National Cancer Institute 2003;95(6):470-8.
2003: Michael W Kattan; James A Eastham
Algorithms for prostate-specific antigen recurrence after treatment of localized prostate cancer.
Clinical prostate cancer 2003;1(4):221-6.
2003: Michael W Kattan
Nomograms are superior to staging and risk grouping systems for identifying high-risk patients: preoperative application in prostate cancer.
Current opinion in urology 2003;13(2):111-6.
2003: Makoto Ohori; Michael W Kattan; Takuji Utsunomiya; Kazuho Suyama; Peter T Scardino; Thomas M Wheeler
Do impalpable stage T1c prostate cancers visible on ultrasound differ from those not visible?
The Journal of urology 2003;169(3):964-8.
2003: Alexander Haese; Markus Graefen; Charlotte Becker; Joachim Noldus; Jared Katz; Ilias Cagiannos; Michael W Kattan; Peter T Scardino; Edith Huland; Hartwig Huland; Hans Lilja
The role of human glandular kallikrein 2 for prediction of pathologically organ confined prostate cancer.
The Prostate 2003;54(3):181-6.
2003: Pierre I Karakiewicz; Michael W Kattan; Simon Tanguay; Mostafa Elhilali; Michel Bazinet; Peter T Scardino; Armen G Aprikian
Cross-cultural validation of the UCLA prostate cancer index.
Urology 2003;61(2):302-7.
2003: Louis Potters; David Huang; Paul Fearn; Michael W Kattan
The effect of isotope selection on the prostate-specific antigen response in patients treated with permanent prostate brachytherapy.
Brachytherapy 2003;2(1):26-31.
2003: Phillip L Ross; Benjamin Littenberg; Paul Fearn; Peter T Scardino; Pierre I Karakiewicz; Michael W Kattan
Paper standard gamble: a paper-based measure of standard gamble utility for current health.
International journal of technology assessment in health care 2003;19(1):135-47.
2002: Beatrice S Knudsen; Glenn A Gmyrek; Jennifer Inra; Douglas Scherr; E Darracott Vaughan; David M Nanus; Michael W Kattan; William L Gerald; George Vande Woude
High expression of the Met receptor in prostate cancer metastasis to bone.
Urology 2002;60(6):1113-7.
2002: James M McKiernan; Ofer Yossepowitch; Michael W Kattan; Rachel Simmons; Robert J Motzer; Victor E Reuter; Paul Russo
Partial nephrectomy for renal cortical tumors: pathologic findings and impact on outcome.
Urology 2002;60(6):1003-9.
2002: Ofer Yossepowitch; Kanishka Sircar; Peter T Scardino; Makoto Ohori; Michael W Kattan; Thomas M Wheeler; Victor E Reuter
Bladder neck involvement in pathological stage pT4 radical prostatectomy specimens is not an independent prognostic factor.
The Journal of urology 2002;168(5):2011-5.
2002: Shahrokh F Shariat; Emanuel Gottenger; Cuong Nguyen; Weitao Song; Michael W Kattan; John Andenoro; Thomas M Wheeler; David M Spencer; Kevin Slawin
Preoperative blood reverse transcriptase-PCR assays for prostate-specific antigen and human glandular kallikrein for prediction of prostate cancer progression after radical prostatectomy.
Cancer research 2002;62(20):5974-9.
2002: Oren Smaletz; Howard I Scher; Eric J Small; David Verbel; Alex McMillan; Kevin Regan; W Kevin Kelly; Michael W Kattan
Nomogram for overall survival of patients with progressive metastatic prostate cancer after castration.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(19):3972-82.
2002: Louis Potters; Rosemary Purrazzella; Sheryl Brustein; Paul Fearn; Steven A Leibel; Michael W Kattan
A comprehensive and novel predictive modeling technique using detailed pathology factors in men with localized prostate carcinoma.
Cancer 2002;95(7):1451-6.
2002: Sara J Knight; Derek P Nathan; Amy K Siston; Michael W Kattan; Arthur S Elstein; Kathleen M Collela; Michael S Wolf; Nicholas S Slimack; Charles L Bennett; Robert M Golub
Pilot study of a utilities-based treatment decision intervention for prostate cancer patients.
Clinical prostate cancer 2002;1(2):105-14.
2002: Michael W Kattan; Peter T Scardino
Prediction of progression: nomograms of clinical utility.
Clinical prostate cancer 2002;1(2):90-6.
2002: Fergus V Coakley; Steven C Eberhardt; Michael W Kattan; David C Wei; Peter T Scardino; Hedvig Hricak
Urinary continence after radical retropubic prostatectomy: relationship with membranous urethral length on preoperative endorectal magnetic resonance imaging.
The Journal of urology 2002;168(3):1032-5.
2002: Markus Graefen; Pierre I Karakiewicz; Ilias Cagiannos; David I Quinn; Susan M Henshall; John J Grygiel; Robert L Sutherland; Phillip D Stricker; Eric Klein; Patrick A Kupelian; Donald G Skinner; Gary Lieskovsky; Bernard H Bochner; Hartwig Huland; Peter Hammerer; Alexander Haese; Andreas Erbersdobler; James A Eastham; Jean de Kernion; Thomas Cangiano; Fritz H Schröder; Mark F Wildhagen; Theo Van der Kwast; Peter T Scardino; Michael W Kattan
International validation of a preoperative nomogram for prostate cancer recurrence after radical prostatectomy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(15):3206-12.
2002: Markus Graefen; Pierre I Karakiewicz; Ilias Cagiannos; Peter Hammerer; Alexander Haese; Jüri Palisaar; Salvador Fernandez; Jochen Noldus; Andreas Erbersdobler; Hartwig Huland; Peter T Scardino; Michael W Kattan
A validation of two preoperative nomograms predicting recurrence following radical prostatectomy in a cohort of European men.
Urologic oncology 2002;7(4):141-6.
2002: Lucille N Lee; Carlton Barnswell; Taryn Torre; Paul Fearn; Michael W Kattan; Louis Potters
Prognostic significance of race on biochemical control in patients with localized prostate cancer treated with permanent brachytherapy: multivariate and matched-pair analyses.
International journal of radiation oncology, biology, physics 2002;53(2):282-9.
2002: Michael W Kattan
Nomograms. Introduction.
Seminars in urologic oncology 2002;20(2):79-81.
2002: James A Eastham; Michael W Kattan; Peter T Scardino
Nomograms as predictive models.
Seminars in urologic oncology 2002;20(2):108-15.
2002: Phillip L Ross; Claudia Gerigk; Mithat Gonen; Ofer Yossepowitch; Ilias Cagiannos; Pramod C Sogani; Peter T Scardino; Michael W Kattan
Comparisons of nomograms and urologists' predictions in prostate cancer.
Seminars in urologic oncology 2002;20(2):82-8.
2002: Ilias Cagiannos; Markus Graefen; Pierre I Karakiewicz; Makoto Ohori; James A Eastham; Farhang Rabbani; William Fair; Thomas M Wheeler; Peter Hammerer; Alexander Haese; Andreas Erbersdobler; Hartwig Huland; Peter T Scardino; Michael W Kattan
Analysis of clinical stage T2 prostate cancer: do current subclassifications represent an improvement?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(8):2025-30.
2002: Colin B Begg; Elyn Riedel; Peter B Bach; Michael W Kattan; Deborah Schrag; Joan L Warren; Peter T Scardino
Variations in morbidity after radical prostatectomy.
The New England journal of medicine 2002;346(15):1138-44.
2002: James A Eastham; Brett S Carver; Jared Katz; Michael W Kattan
Clinical stage T1c prostate cancer: pathologic outcomes following radical prostatectomy in black and white men.
The Prostate 2002;50(4):236-40.
2002: Markus Graefen; Pierre I Karakiewicz; Ilias Cagiannos; Peter Hammerer; Alexander Haese; Jüri Palisaar; Edith Huland; Peter T Scardino; Michael W Kattan; Hartwig Huland
Percent free prostate specific antigen is not an independent predictor of organ confinement or prostate specific antigen recurrence in unscreened patients with localized prostate cancer treated with radical prostatectomy.
The Journal of urology 2002;167(3):1306-9.
2002: Markus Graefen; Pierre I Karakiewicz; Ilias Cagiannos; Eric Klein; Patrick A Kupelian; David I Quinn; Susan M Henshall; John J Grygiel; Robert L Sutherland; Phillip D Stricker; Jean de Kernion; Thomas Cangiano; Fritz H Schröder; Mark F Wildhagen; Peter T Scardino; Michael W Kattan
Validation study of the accuracy of a postoperative nomogram for recurrence after radical prostatectomy for localized prostate cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(4):951-6.
2002: Michael W Kattan
Statistical prediction models, artificial neural networks, and the sophism "I am a patient, not a statistic".
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(4):885-7.
2002: Shahrokh F Shariat; Dolores J Lamb; Michael W Kattan; Cuong Nguyen; JaHong Kim; Josie Beck; Thomas M Wheeler; Kevin Slawin
Association of preoperative plasma levels of insulin-like growth factor I and insulin-like growth factor binding proteins-2 and -3 with prostate cancer invasion, progression, and metastasis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(3):833-41.
2002: Michael W Kattan; Denis H Y Leung; Murray F Brennan
Postoperative nomogram for 12-year sarcoma-specific death.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(3):791-6.
2002: Jerry Hull; Farhang Rabbani; Farhat Abbas; Thomas M Wheeler; Michael W Kattan; Peter T Scardino
Cancer control with radical prostatectomy alone in 1,000 consecutive patients.
The Journal of urology 2002;167(2 Pt 1):528-34.
2002: Kevin Slawin; Eduardo I Canto; Shahrokh F Shariat; John L Gore; Edward Kim; Michael W Kattan; Thomas M Wheeler; Rahul K Nath
Sural Nerve Interposition Grafting during Radical Prostatectomy.
Reviews in urology 2002;4(1):17-23.
2002: Louis Potters; Paul Fearn; Michael W Kattan
The role of external radiotherapy in patients treated with permanent prostate brachytherapy.
Prostate cancer and prostatic diseases 2002;5(1):47-53.
2002: Louis Potters; Paul Fearn; Michael W Kattan
External radiotherapy and permanent prostate brachytherapy in patients with localized prostate cancer.
Brachytherapy 2002;1(1):36-41.
2001: Shahrokh F Shariat; J H Kim; Ben Andrews; Michael W Kattan; Thomas M Wheeler; Isaac Yi Kim; Seth P Lerner; Kevin Slawin
Preoperative plasma levels of transforming growth factor beta(1) strongly predict clinical outcome in patients with bladder carcinoma.
Cancer 2001;92(12):2985-92.
2001: Shahrokh F Shariat; Ben Andrews; Michael W Kattan; JaHong Kim; Thomas M Wheeler; Kevin Slawin
Plasma levels of interleukin-6 and its soluble receptor are associated with prostate cancer progression and metastasis.
Urology 2001;58(6):1008-15.
2001: P S Kothari; Peter T Scardino; Makoto Ohori; Michael W Kattan; Thomas M Wheeler
Incidence, location, and significance of periprostatic and periseminal vesicle lymph nodes in prostate cancer.
The American journal of surgical pathology 2001;25(11):1429-32.
2001: Michael W Kattan; Louis Potters; John C Blasko; David C Beyer; Paul Fearn; William Cavanagh; Steven Leibel; Peter T Scardino
Pretreatment nomogram for predicting freedom from recurrence after permanent prostate brachytherapy in prostate cancer.
Urology 2001;58(3):393-9.
2001: Norio Maru; Makoto Ohori; Michael W Kattan; Peter T Scardino; Thomas M Wheeler
Prognostic significance of the diameter of perineural invasion in radical prostatectomy specimens.
Human pathology 2001;32(8):828-33.
2001: Louis Potters; Taryn Torre; Paul Fearn; Steven A Leibel; Michael W Kattan
Potency after permanent prostate brachytherapy for localized prostate cancer.
International journal of radiation oncology, biology, physics 2001;50(5):1235-42.
2001: Michael W Kattan; Victor E Reuter; Robert J Motzer; J Katz; Paul Russo
A postoperative prognostic nomogram for renal cell carcinoma.
The Journal of urology 2001;166(1):63-7.
2001: Shahrokh F Shariat; M Shalev; Andres Menesses-Diaz; Isaac Yi Kim; Michael W Kattan; Thomas M Wheeler; Kevin Slawin
Preoperative plasma levels of transforming growth factor beta(1) (TGF-beta(1)) strongly predict progression in patients undergoing radical prostatectomy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(11):2856-64.
2001: Phillip L Ross; Peter T Scardino; Michael W Kattan
A catalog of prostate cancer nomograms.
The Journal of urology 2001;165(5):1562-8.
2001: R R Byrne; Shahrokh F Shariat; R Brown; Michael W Kattan; J R Morton RA; Thomas M Wheeler; Seth P Lerner
E-cadherin immunostaining of bladder transitional cell carcinoma, carcinoma in situ and lymph node metastases with long-term followup.
The Journal of urology 2001;165(5):1473-9.
2001: C M Herman; Michael W Kattan; Makoto Ohori; Peter T Scardino; Thomas M Wheeler
Primary Gleason pattern as a predictor of disease progression in gleason score 7 prostate cancer: a multivariate analysis of 823 men treated with radical prostatectomy.
The American journal of surgical pathology 2001;25(5):657-60.
2001: AK Leventis; Shahrokh F Shariat; Michael W Kattan; E B Butler; Thomas M Wheeler; Kevin Slawin
Prediction of response to salvage radiation therapy in patients with prostate cancer recurrence after radical prostatectomy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(4):1030-9.
2001: Michael W Kattan; Paul Fearn; BJ Miles
Time trade-off utility modified to accommodate degenerative and life-threatening conditions.
Proceedings / AMIA ... Annual Symposium. AMIA Symposium 2001;():304-8.
2000: Kevin Slawin; Shahrokh F Shariat; Cuong Nguyen; AK Leventis; Weitao Song; Michael W Kattan; C Y Young; D J Tindall; Thomas M Wheeler
Detection of metastatic prostate cancer using a splice variant-specific reverse transcriptase-polymerase chain reaction assay for human glandular kallikrein.
Cancer research 2000;60(24):7142-8.
2000: Michael W Kattan; Paul Fearn; Steven Leibel; Louis Potters
The definition of biochemical failure in patients treated with definitive radiotherapy.
International journal of radiation oncology, biology, physics 2000;48(5):1469-74.
2000: Farhang Rabbani; A M Stapleton; Michael W Kattan; Thomas M Wheeler; Peter T Scardino
Factors predicting recovery of erections after radical prostatectomy.
The Journal of urology 2000;164(6):1929-34.
2000: Michael L Blute; E J Bergstralh; Alan W Partin; Patrick C Walsh; Michael W Kattan; Peter T Scardino; James E Montie; Jay D Pearson; J M Slezak; Horst Zincke
Validation of Partin tables for predicting pathological stage of clinically localized prostate cancer.
The Journal of urology 2000;164(5):1591-5.
2000: Scott B Cantor; Michael W Kattan
Determining the area under the ROC curve for a binary diagnostic test.
Medical decision making : an international journal of the Society for Medical Decision Making 2000;20(4):468-70.
2000: Michael W Kattan; Michael J Zelefsky; Patrick A Kupelian; Peter T Scardino; Zvi Fuks; Steven A Leibel
Pretreatment nomogram for predicting the outcome of three-dimensional conformal radiotherapy in prostate cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(19):3352-9.
2000: MA Sutton; C T F Freund; SA Berkman; Truong D Dang; Michael W Kattan; Thomas M Wheeler; David R Rowley; Seth P Lerner
In vivo adenovirus-mediated suicide gene therapy of orthotopic bladder cancer.
Molecular therapy : the journal of the American Society of Gene Therapy 2000;2(3):211-7.
2000: Shahrokh F Shariat; F Bergamaschi; H L Adler; Cuong Nguyen; Michael W Kattan; Thomas M Wheeler; Kevin Slawin
Correlation of preoperative plasma IGF-I levels with pathologic parameters and progression in patients undergoing radical prostatectomy.
Urology 2000;56(3):423-9.
2000: Blaz Zupan; Janez Demsar; Michael W Kattan; J Robert Beck; Ivan Bratko
Machine learning for survival analysis: a case study on recurrence of prostate cancer.
Artificial intelligence in medicine 2000;20(1):59-75.
2000: C M Herman; G E Wilcox; Michael W Kattan; Peter T Scardino; Thomas M Wheeler
Lymphovascular invasion as a predictor of disease progression in prostate cancer.
The American journal of surgical pathology 2000;24(6):859-63.
2000: Sarah E Blutt; Tara C Polek; LaMonica V Stewart; Michael W Kattan; Nancy L Weigel
A calcitriol analogue, EB1089, inhibits the growth of LNCaP tumors in nude mice.
Cancer research 2000;60(4):779-82.
2000: RB Giesler; B J Miles; M E Cowen; Michael W Kattan
Assessing quality of life in men with clinically localized prostate cancer: development of a new instrument for use in multiple settings.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2000;9(6):645-65.
2000: James A Eastham; Michael W Kattan
Disease recurrence in black and white men undergoing radical prostatectomy for clinical stage T1-T2 prostate cancer.
The Journal of urology 2000;163(1):143-5.
1999: M N Witte; Michael W Kattan; J Albani; D S Sharp; James A Eastham; Ronald A Morton
Race is not an independent predictor of positive surgical margins after radical prostatectomy.
Urology 1999;54(5):869-74.
1999: James A Eastham; R May; J L Robertson; O Sartor; Michael W Kattan
Development of a nomogram that predicts the probability of a positive prostate biopsy in men with an abnormal digital rectal examination and a prostate-specific antigen between 0 and 4 ng/mL.
Urology 1999;54(4):709-13.
1999: Sibel Erdamar; Guang Yang; J Wade Harper; X Lu; Michael W Kattan; Timothy C Thompson; Thomas M Wheeler
Levels of expression of p27KIP1 protein in human prostate and prostate cancer: an immunohistochemical analysis.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 1999;12(8):751-5.
1999: RC Anton; Michael W Kattan; S Chakraborty; Thomas M Wheeler
Postatrophic hyperplasia of the prostate: lack of association with prostate cancer.
The American journal of surgical pathology 1999;23(8):932-6.
1999: Michael W Kattan; Thomas M Wheeler; Peter T Scardino
Postoperative nomogram for disease recurrence after radical prostatectomy for prostate cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(5):1499-507.
1999: William S Kubricht; Michael W Kattan; O Sartor; James A Eastham
Race is not independently associated with a positive prostate biopsy in men suspected of having prostate cancer.
Urology 1999;53(3):553-6.
1999: Makoto Ohori; F Abbas; Thomas M Wheeler; Michael W Kattan; Peter T Scardino; Seth P Lerner
Pathological features and prognostic significance of prostate cancer in the apical section determined by whole mount histology.
The Journal of urology 1999;161(2):500-4.
1999: Janez Demsar; Blaz Zupan; Michael W Kattan; J Robert Beck; Ivan Bratko
Naive Bayesian-based nomogram for prediction of prostate cancer recurrence.
Studies in health technology and informatics 1999;68():436-41.
1999: Michael W Kattan; Paul Fearn; S B Cantor; J Hu; M E Cowen; RB Giesler; BJ Miles
Telephone interviews vs. workstation sessions for acquiring quality of life data.
Proceedings / AMIA ... Annual Symposium. AMIA Symposium 1999;():296-300.
1999: HL Adler; MA McCurdy; Michael W Kattan; Terry L Timme; Peter T Scardino; Timothy C Thompson
Elevated levels of circulating interleukin-6 and transforming growth factor-beta1 in patients with metastatic prostatic carcinoma.
The Journal of urology 1999;161(1):182-7.
1999: Brian J Miles; B Giesler; Michael W Kattan
Recall and attitudes in patients with prostate cancer.
Urology 1999;53(1):169-74.
1998: J C Hu; GS Palapattu; Michael W Kattan; Peter T Scardino; Thomas M Wheeler
The association of selected pathological features with prostate cancer in a single-needle biopsy accession.
Human pathology 1998;29(12):1536-8.
1998: M E Cowen; BJ Miles; D F Cahill; RB Giesler; J Robert Beck; Michael W Kattan
The danger of applying group-level utilities in decision analyses of the treatment of localized prostate cancer in individual patients.
Medical decision making : an international journal of the Society for Medical Decision Making 1998;18(4):376-80.
1998: Michael W Kattan; K R Hess; J Robert Beck
Experiments to determine whether recursive partitioning (CART) or an artificial neural network overcomes theoretical limitations of Cox proportional hazards regression.
Computers and biomedical research, an international journal 1998;31(5):363-73.
1998: Guang Yang; Luan D Truong; Terry L Timme; Chengzhen Ren; Thomas M Wheeler; Sang Hee Park; Yasutomo Nasu; CH Bangma; Michael W Kattan; Peter T Scardino; Timothy C Thompson
Elevated expression of caveolin is associated with prostate and breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 1998;4(8):1873-80.
1998: Thomas M Wheeler; O Dillioglugil; Michael W Kattan; A Arakawa; Shigehiro Soh; K Suyama; Makoto Ohori; Peter T Scardino
Clinical and pathological significance of the level and extent of capsular invasion in clinical stage T1-2 prostate cancer.
Human pathology 1998;29(8):856-62.
1998: BD Leibman; O Dillioglugil; F Abbas; S Tanli; Michael W Kattan; Peter T Scardino
Impact of a clinical pathway for radical retropubic prostatectomy.
Urology 1998;52(1):94-9.
1998: BD Leibman; O Dillioglugil; Peter T Scardino; F Abbas; E Rogers; R D Wolfinger; Michael W Kattan
Prostate-specific antigen doubling times are similar in patients with recurrence after radical prostatectomy or radiotherapy: a novel analysis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(6):2267-71.
1998: Ori Hampel; Michael W Kattan; Guang Yang; Sigmund Haidacher; George Y Saleh; Timothy C Thompson; Thomas M Wheeler; Marco Marcelli
Quantitative immunohistochemical analysis of insulin-like growth factor binding protein-3 in human prostatic adenocarcinoma: a prognostic study.
The Journal of urology 1998;159(6):2220-5.
1998: Michael W Kattan; James A Eastham; A M Stapleton; T M Wheeler; Peter T Scardino
A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer.
Journal of the National Cancer Institute 1998;90(10):766-71.
1998: YH Kim; C Goodman; E Omessi; V Rivera; Michael W Kattan; Timothy B Boone
The correlation of urodynamic findings with cranial magnetic resonance imaging findings in multiple sclerosis.
The Journal of urology 1998;159(3):972-6.
1998: YH Kim; Michael W Kattan; Timothy B Boone
Bladder leak point pressure: the measure for sphincterotomy success in spinal cord injured patients with external detrusor-sphincter dyssynergia.
The Journal of urology 1998;159(2):493-6; discussion 496-7.
1998: A M Stapleton; P Zbell; Michael W Kattan; Guang Yang; Thomas M Wheeler; Peter T Scardino; Timothy C Thompson
Assessment of the biologic markers p53, Ki-67, and apoptotic index as predictive indicators of prostate carcinoma recurrence after surgery.
Cancer 1998;82(1):168-75.
1997: Y H Kim; Michael W Kattan; Timothy B Boone
Correlation of urodynamic results and urethral coaptation with success after transurethral collagen injection.
Urology 1997;50(6):941-8.
1997: J R Gingrich; R J Barrios; Michael W Kattan; HS Nahm; M J Finegold; Norman M Greenberg
Androgen-independent prostate cancer progression in the TRAMP model.
Cancer research 1997;57(21):4687-91.
1997: James A Eastham; Michael W Kattan; S Groshen; Peter T Scardino; E Rogers; C E Carlton; Seth P Lerner
Fifteen-year survival and recurrence rates after radiotherapy for localized prostate cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(10):3214-22.
1997: A M Stapleton; Terry L Timme; Angelo E Gousse; Q F Li; A A Tobon; Michael W Kattan; Kevin Slawin; Thomas M Wheeler; Peter T Scardino; Timothy C Thompson
Primary human prostate cancer cells harboring p53 mutations are clonally expanded in metastases.
Clinical cancer research : an official journal of the American Association for Cancer Research 1997;3(8):1389-97.
1997: O Dillioglugil; BD Leibman; Michael W Kattan; C Seale-Hawkins; Thomas M Wheeler; Peter T Scardino
Hazard rates for progression after radical prostatectomy for clinically localized prostate cancer.
Urology 1997;50(1):93-9.
1997: Shigehiro Soh; Michael W Kattan; S Berkman; Thomas M Wheeler; Peter T Scardino
Has there been a recent shift in the pathological features and prognosis of patients treated with radical prostatectomy?
The Journal of urology 1997;157(6):2212-8.
1997: Alan W Partin; Michael W Kattan; EN Subong; Patrick C Walsh; Kirk J Wojno; JE Oesterling; Peter T Scardino; Jay D Pearson
Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update.
JAMA : the journal of the American Medical Association 1997;277(18):1445-51.
1997: Michael W Kattan; Mark E Cowen; B J Miles
A decision analysis for treatment of clinically localized prostate cancer.
Journal of general internal medicine 1997;12(5):299-305.
1997: O Dillioglugil; BD Leibman; N S Leibman; Michael W Kattan; A L Rosas; Peter T Scardino
Risk factors for complications and morbidity after radical retropubic prostatectomy.
The Journal of urology 1997;157(5):1760-7.
1997: MA Sutton; SA Berkman; SH Chen; A Block; Truong D Dang; Michael W Kattan; Thomas M Wheeler; David R Rowley; SL Woo; Seth P Lerner
Adenovirus-mediated suicide gene therapy for experimental bladder cancer.
Urology 1997;49(2):173-80.
1997: Michael W Kattan; A M Stapleton; Thomas M Wheeler; Peter T Scardino
Evaluation of a nomogram used to predict the pathologic stage of clinically localized prostate carcinoma.
Cancer 1997;79(3):528-37.
1997: RJ Henderson; James A Eastham; D J Culkin; Michael W Kattan; T Whatley; J Mata; Dennis D Venable; O Sartor
Prostate-specific antigen (PSA) and PSA density: racial differences in men without prostate cancer.
Journal of the National Cancer Institute 1997;89(2):134-8.
1996: G M Marley; M C Miller; Michael W Kattan; G Zhao; K P Patton; R L Vessella; G L Wright; P F Schellhammer; Robert W Veltri
Free and complexed prostate-specific antigen serum ratios to predict probability of primary prostate cancer and benign prostatic hyperplasia.
Urology 1996;48(6A Suppl):16-22.
1996: Mark E Cowen; Michael W Kattan; B J Miles
A national survey of attitudes regarding participation in prostate carcinoma testing.
Cancer 1996;78(9):1952-7.
1996: James A Eastham; Michael W Kattan; E Rogers; J R Goad; Makoto Ohori; Timothy B Boone; Peter T Scardino
Risk factors for urinary incontinence after radical prostatectomy.
The Journal of urology 1996;156(5):1707-13.
1996: Michael W Kattan; Y Inoue; Francis Giles; Moshe Talpaz; Howard Ozer; françois guilhot; E Zuffa; S L Huber; J Robert Beck
Cost-effectiveness of interferon-alpha and conventional chemotherapy in chronic myelogenous leukemia.
Annals of internal medicine 1996;125(7):541-8.
1996: Guang Yang; Thomas M Wheeler; Michael W Kattan; Peter T Scardino; Timothy C Thompson
Perineural invasion of prostate carcinoma cells is associated with reduced apoptotic index.
Cancer 1996;78(6):1267-71.
1996: E Rogers; T Gürpinar; O Dillioglugil; Michael W Kattan; J R Goad; Peter T Scardino; D P Griffith
The role of digital rectal examination, biopsy Gleason sum and prostate-specific antigen in selecting patients who require pelvic lymph node dissections for prostate cancer.
British journal of urology 1996;78(3):419-25.
1996: Y Goto; Makoto Ohori; A Arakawa; Michael W Kattan; Thomas M Wheeler; Peter T Scardino
Distinguishing clinically important from unimportant prostate cancers before treatment: value of systematic biopsies.
The Journal of urology 1996;156(3):1059-63.
1996: Mark E Cowen; Michael W Kattan; B J Miles
Survival and conservative treatment for localized prostate cancer.
JAMA : the journal of the American Medical Association 1996;275(1):31-2.
1996: T Gürpinar; S Gürer; Michael W Kattan; L Wang; D P Griffith
Laser-welded ureteral anastomoses: experimental studies with three techniques.
Techniques in urology 1996;2(2):117-20.
1996: Michael W Kattan; Mark E Cowen; B J Miles
Computer modeling in urology.
Urology 1996;47(1):14-21.
1995: J R Goad; James A Eastham; K B Fitzgerald; Michael W Kattan; M P Collini; D H Yawn; Peter T Scardino
Radical retropubic prostatectomy: limited benefit of autologous blood donation.
The Journal of urology 1995;154(6):2103-9.
1995: Makoto Ohori; Thomas M Wheeler; Michael W Kattan; Y Goto; Peter T Scardino
Prognostic significance of positive surgical margins in radical prostatectomy specimens.
The Journal of urology 1995;154(5):1818-24.
1995: James A Eastham; Luan D Truong; E Rogers; Michael W Kattan; K C Flanders; Peter T Scardino; Timothy C Thompson
Transforming growth factor-beta 1: comparative immunohistochemical localization in human primary and metastatic prostate cancer.
Laboratory investigation; a journal of technical methods and pathology 1995;73(5):628-35.
1995: Michael W Kattan; J Robert Beck
Artificial neural networks for medical classification decisions.
Archives of pathology & laboratory medicine 1995;119(8):672-7.
1995: B J Miles; Michael W Kattan; R B Giesler; Mark E Cowen
Screening for prostate cancer.
JAMA : the journal of the American Medical Association 1995;273(15):1173-4; author reply 1175-6.
1995: B J Miles; Michael W Kattan
Computer modeling of prostate cancer treatment. A paradigm for oncologic management?
Surgical oncology clinics of North America 1995;4(2):361-72.
1994: J Robert Beck; Michael W Kattan; B J Miles
A critique of the decision analysis for clinically localized prostate cancer.
The Journal of urology 1994;152(5 Pt 2):1894-9.
1994: Michael W Kattan; D A Adams
Explaining information technology use with the usefulness scale: a comparison with user age.
Proceedings / the ... Annual Symposium on Computer Application [sic] in Medical Care. Symposium on Computer Applications in Medical Care 1994;():81-5.
1993: Jan C Liang; N M Bailey; G J Gabriel; Michael W Kattan; R Y Wang; F B Hagemeister; Fernando Cabanillas; Lillian M Fuller
A new chemotherapy regimen for treatment of Hodgkin's disease associated with minimal genotoxicity.
Leukemia & lymphoma 1993;9(6):503-8.